<SEC-DOCUMENT>0001839882-26-023278.txt : 20260507
<SEC-HEADER>0001839882-26-023278.hdr.sgml : 20260507
<ACCEPTANCE-DATETIME>20260507114513
ACCESSION NUMBER:		0001839882-26-023278
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		13
FILED AS OF DATE:		20260507
DATE AS OF CHANGE:		20260507

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			UBS AG
		CENTRAL INDEX KEY:			0001114446
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283672
		FILM NUMBER:		26951801

	BUSINESS ADDRESS:	
		STREET 1:		BAHNHOFSTRASSE 45
		CITY:			ZURICH
		STATE:			V8
		ZIP:			CH 8001
		BUSINESS PHONE:		203-719-5241

	MAIL ADDRESS:	
		STREET 1:		600 WASHINGTON BLVD.
		CITY:			STAMFORD
		STATE:			CT
		ZIP:			06901
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ubs_424b2-15052.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
    <HEAD>
        <TITLE></TITLE>
<!-- QES 7h3d0c70r 1778027338.5486686 -->
    </HEAD>
    <BODY style="text-decoration-skip-ink: none; ">
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 15.84pt 39.60pt 0 39.60pt; min-height: 23.76pt; position: relative; ">
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="text-align: right; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Filed Pursuant to Rule 424(b)(2)</font><BR><font style='white-space: pre-wrap;'>Registration Statement No. 333-283672</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="21.52%" style="width: 21.52%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="88.48%" style="width: 88.48%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; vertical-align: middle; ">
                            <P style="text-align: center; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-size: 6.0pt; font-family: Arial, sans-serif; ">                                    <IMG width="104.28pt" height="38.06pt" src="image1.jpg" style="width: 104.28pt; height: 38.06pt; ">
                                    </FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: center; margin-top: 1.1pt;margin-left: -110pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 18.0pt; "><font style='white-space: pre-wrap;'>UBS AG</font></FONT></P>
                            <P style="text-align: center; margin-top: 1.1pt;margin-left: -110pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>$871,000</font></FONT></P>
                            <P style="text-align: justify; margin-top: 1.1pt;margin-left: 20pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Capped Leveraged Buffered MSCI EAFE</font></FONT><FONT style="font-family: Arial, sans-serif; vertical-align: super; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> Index-Linked Medium-Term Notes due June 9, 2028</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: justify; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>The notes do not bear interest. </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>The amount that you will be paid on your notes on the stated maturity date (June 9, 2028) is based on the performance of the MSCI EAFE</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 6pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> Index as measured from the trade date (May 5, 2026) to and including the determination date (June 7, 2028). If the final underlier level on the determination date is greater than the initial underlier level of 3,026.84, the return on your notes will be positive, subject to the maximum settlement amount of $1,296.80 for each $1,000 face amount of your notes. If the final underlier level declines by up to 15.00% from the initial underlier level, you will receive the face amount of your notes. </font></FONT><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>If the final underlier level declines by more than 15.00%</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>from the initial underlier level, the return on your notes will be negative.</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Specifically, you will lose approximately 1.1765%</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>of the face amount of your notes for every 1% negative underlier return below the buffer level of 85.00% of the initial underlier level. You could lose your entire investment in the notes.</font></FONT></P>
                <P style="text-align: justify; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>To determine your cash settlement amount, we will calculate the underlier return, which is the percentage increase or decrease in the final underlier level from the initial underlier level. On the stated maturity date, for each $1,000 face amount of your notes, you will receive an amount in cash equal to: </font></FONT></P>
                <P style="text-align: justify; margin-top: 1.1pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>if the underlier return is </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>positive</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> (the final underlier level is </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>greater than</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> the initial underlier level), the </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>sum</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> of (i)&#160;$1,000 </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>plus</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> (ii)&#160;the </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>product</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> of (a)&#160;$1,000 </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>times</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> (b)&#160;the upside participation rate of 160.00% </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>times</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> (c)&#160;the underlier return, subject to the maximum settlement amount;</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 1.1pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>if the underlier return is </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>zero</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> or </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>negative</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> but </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>not</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>below</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> -15.00% (the final underlier level is </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>equal to</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> or </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>less than</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> the initial underlier level but not by more than 15.00%), $1,000; or</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 1.1pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>if the underlier return is </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>negative</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> and is </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>below</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> -15.00% (the final underlier level is </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>less than </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>the initial underlier level by more than 15.00%), the </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>sum</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> of (i) $1,000 </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>plus</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> (ii) the </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>product</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> of (a) approximately 117.65% </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>times</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> (b) the </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>sum of</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> the underlier return plus 15.00% </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>times</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> (c) $1,000. </font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Your investment in the notes involves certain risks, including, among other things, our credit risk. See &#8220;Additional Risk Factors Specific To Your Notes&#8221; beginning on page 9 herein.</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> You should read the additional disclosure herein so that you may better understand the terms and risks of your investment. </font></FONT></P>
                <P style="margin-top: 1.1pt; margin-bottom: 4.4pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>The estimated initial value of the notes as of the trade date is $996.90 per $1,000 face amount. The estimated initial value of the notes was determined as of the close of the relevant markets on the date hereof by reference to UBS&#8217; internal pricing models, inclusive of the internal funding rate. For more information about secondary market offers and the estimated initial value of the notes, see &#8220;Additional Risk Factors Specific To Your Notes &#8212;&#160;Estimated Value Considerations&#8221; and &#8220;&#8212;&#160;Risks Relating to Liquidity and Secondary Market Price Considerations&#8221; beginning on page 11 herein.</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="21.08%" style="width: 21.08%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="32.08%" style="width: 32.08%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="23.83%" style="width: 23.83%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="33.00%" style="width: 33.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Original issue date:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: right; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>May 8, 2026 </font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Original issue price:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: right; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00% of the face amount</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Underwriting discount*:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: right; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>0.00% of the face amount</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: justify; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Net proceeds to the issuer*:</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="text-align: right; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>100.00% of the face amount</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="margin-top: 4.4pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>* For additional information, see &#8220;Supplemental plan of distribution (conflicts of interest); secondary markets (if any)&#8221; herein.</font></FONT></P>
                <P style="margin-top: 4.4pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these notes or passed upon the accuracy or adequacy of this document, the accompanying product supplement, the accompanying index supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense. The notes are not bank deposits and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency. </font></FONT></P>
                <P style="margin-top: 4.4pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 18.0pt; "><font style='white-space: pre-wrap;'>UBS Securities LLC</font></FONT></P>
                <P style="margin-top: 4.4pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Pricing Supplement dated May 5, 2026</font></FONT></P>
                <P style="text-align: justify; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>The issue price, underwriting discount and net proceeds listed above relate to the notes we sell initially. We may decide to sell additional notes after the date of this pricing supplement, at issue prices and with underwriting discounts and net proceeds that differ from the amounts set forth above. The return (whether positive or negative) on your investment in the notes will depend in part on the issue price you pay for such notes. </font></FONT></P>
                <P style="text-align: justify; margin-top: 1.1pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>UBS Securities LLC, our affiliate, will purchase the notes from UBS for distribution to one or more registered broker dealers (&#8220;dealers&#8221;). UBS Securities LLC, the dealers or any of their respective affiliates may use this document in market-making transactions in notes after their initial sale. </font></FONT><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>Unless UBS, UBS Securities LLC, the dealers or any of their respective affiliates selling such notes to you informs you otherwise in the confirmation of sale, this pricing supplement is being used in a market-making transaction. </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>See &#8220;Supplemental plan of distribution (conflicts of interest); secondary markets (if any)&#8221; herein and &#8220;Supplemental Plan of Distribution (Conflicts of Interest)&#8221; in the accompanying product supplement.</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 23.76pt 39.60pt; min-height: 15.84pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-bottom: 6.6pt; text-align: center; margin-top: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; text-transform: uppercase; "><font style='white-space: pre-wrap;'>SUMMARY INFORMATION</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: -3.96pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 3.96pt; padding-right: 3.96pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="text-align: justify; margin-top: 6.6pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>UBS has filed a registration statement (including a prospectus, as supplemented by a product supplement for the notes and an index supplement for various securities we may offer, including the notes), with the Securities and Exchange Commission, or SEC, for the offering to which this document relates. You should read these documents and any other documents relating to this offering that UBS has filed with the SEC for more complete information about UBS and this offering. You may obtain these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Our Central Index Key, or CIK, on the SEC website is 0001114446.</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 3.96pt; padding-right: 3.96pt; padding-bottom: 0.0pt; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 6.6pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You may access these documents on the SEC website at www.sec.gov as follows:</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 86.73pt; ">
                        <TD style="padding-top: 0.0pt; padding-left: 0.00pt; padding-right: 0.00pt; padding-bottom: 0.0pt; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 4.4pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -9.52pt; "><!--[if IE]<FONT style="display: inline-block; width: 9.52pt; text-indent: -9.52pt; "><![endif]--><FONT style="display: inline-block; width: 9.52pt; text-indent: 0; text-align: left; font-size: 8.5pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Underlier-Linked Notes product supplement dated February 7, 2025:</font><BR></FONT><A href="http://www.sec.gov/Archives/edgar/data/1114446/000183988225007892/ubs_424b2-04013.htm" style="word-break: break-all; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; color: #0000FF; text-decoration-style: solid; text-decoration-line: underline; "><U><font style='white-space: pre-wrap;'>http://www.sec.gov/Archives/edgar/data/1114446/000183988225007892/ubs_424b2</font></U><U><font style='white-space: pre-wrap;'>-</font></U><U><font style='white-space: pre-wrap;'>04013.htm</font></U></FONT></A><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></FONT></P>
                            <P style="margin-top: 4.4pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -9.52pt; "><!--[if IE]<FONT style="display: inline-block; width: 9.52pt; text-indent: -9.52pt; "><![endif]--><FONT style="display: inline-block; width: 9.52pt; text-indent: 0; text-align: left; font-size: 8.5pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Index Supplement dated February 6, 2025:</font><BR></FONT><A href="http://www.sec.gov/Archives/edgar/data/1114446/000183988225007688/ubs_424b2-03745.htm" style="word-break: break-all; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; color: #0000FF; text-decoration-style: solid; text-decoration-line: underline; "><U><font style='white-space: pre-wrap;'>http://www.sec.gov/Archives/edgar/data/1114446/000183988225007688/ubs_424b2</font></U><U><font style='white-space: pre-wrap;'>-</font></U><U><font style='white-space: pre-wrap;'>03745.htm</font></U></FONT></A><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></FONT></P>
                            <P style="margin-top: 4.4pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -9.52pt; "><!--[if IE]<FONT style="display: inline-block; width: 9.52pt; text-indent: -9.52pt; "><![endif]--><FONT style="display: inline-block; width: 9.52pt; text-indent: 0; text-align: left; font-size: 8.5pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Prospectus dated February 6, 2025:</font><BR></FONT><A href="http://www.sec.gov/Archives/edgar/data/1114446/000119312525021845/d936490d424b3.htm" style="word-break: break-all; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; color: #0000FF; text-decoration-style: solid; text-decoration-line: underline; "><U><font style='white-space: pre-wrap;'>http://www.sec.gov/Archives/edgar/data/1114446/000119312525021845/d936490d424b3.htm</font></U></FONT></A><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 12.0pt; padding-left: 3.96pt; padding-right: 3.96pt; padding-bottom: 0.0pt; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>References to &#8220;UBS,&#8221; &#8220;we,&#8221; &#8220;our&#8221; and &#8220;us&#8221; refer only to UBS AG and not to its consolidated subsidiaries. In this document, &#8220;notes&#8221; refer to the Capped Leveraged Buffered MSCI EAFE</font></FONT><FONT style="font-family: Arial, sans-serif; vertical-align: super; font-size: 7pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> Index-Linked Medium-Term Notes that are offered hereby, unless the context otherwise requires. Also, references to the &#8220;accompanying product supplement&#8221; mean the UBS Underlier-Linked Notes product supplement, dated February 7, 2025, references to the &#8220;accompanying index supplement&#8221; mean the UBS index supplement dated February 6, 2025 and references to the &#8220;accompanying prospectus&#8221; mean the UBS prospectus titled &#8220;Debt Securities and Warrants,&#8221; dated February 6, 2025.</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 3.96pt; padding-right: 3.96pt; padding-bottom: 0.0pt; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="text-align: justify; margin-top: 6.6pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>This document, together with the documents listed above, contains the terms of the notes and supersedes all other prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other things, the matters set forth in &#8220;Additional Risk Factors Specific To Your Notes&#8221; herein and in &#8220;Risk Factors&#8221; in the accompanying product supplement, as the notes involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax and other advisors concerning an investment in the notes.</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 3.96pt; padding-right: 3.96pt; padding-bottom: 0.0pt; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="text-align: justify; margin-top: 6.6pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>UBS reserves the right to change the terms of, or reject any offer to purchase, the notes prior to their issuance. In the event of any changes to the terms of the notes, UBS will notify you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes in which case UBS may reject your offer to purchase.</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>&nbsp;</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>ii</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; text-transform: uppercase; "><font style='white-space: pre-wrap;'>INVESTOR SUITABILITY</font></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The notes may be suitable for you if:</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You fully understand the risks inherent in an investment in the notes, including the risk of loss of your entire initial investment.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You can tolerate a loss of all or a substantial portion of your investment and are willing to make an investment that may have the full downside market risk of an investment in the stocks comprising the underlier (the &#8220;underlier stocks&#8221;), subject to the buffer level.</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You believe that the level of the underlier will appreciate over the term of the notes and that the final underlier level is unlikely to exceed the cap level, which is 118.55% of the initial underlier level.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You understand and accept that your return on the notes is limited by the maximum settlement amount and you are willing to invest in the notes based on the maximum settlement amount of $1,296.80 for each $1,000.00 face amount of your notes.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You can tolerate fluctuations in the price of the notes throughout their term that may be similar to or exceed the downside fluctuations in the level of the underlier or the price of the underlier stocks. </font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You do not seek guaranteed current income from your investment and are willing to forgo any dividends paid on the underlier stocks.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You are willing to hold the notes to maturity, a term of approximately 25 months, and accept that there may be little or no secondary market for the notes.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You seek an investment with exposure to companies in the developed markets of Europe, Asia, Australia and the Far East.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You are willing to assume the credit risk of UBS for all payments under the notes, and understand that if UBS defaults on its obligations you may not receive any amounts due to you including any repayment of principal.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You understand that the estimated initial value of the notes determined by our internal pricing models is lower than the issue price and that should UBS Securities LLC or any affiliate make secondary markets for the notes, the price (not including their customary bid-ask spreads) will temporarily exceed the internal pricing model price.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The notes may not be suitable for you if:</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You do not fully understand the risks inherent in an investment in the notes, including the risk of loss of your entire initial investment.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You require an investment designed to guarantee a full return of principal at maturity.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You cannot tolerate a loss of all or a substantial portion of your investment or are not willing to make an investment that may have the full downside market risk of an investment in the underlier stocks, subject to the buffer level.</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You believe that the level of the underlier will decline during the term of the notes and the final underlier level will likely be less than the initial underlier level by more than 15.00%</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>,</font></FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'> or you believe that the level of the underlier will appreciate over the term of the notes and that the final underlier level is likely to exceed the cap level, which is 118.55% of the initial underlier level.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You seek an investment that has unlimited return potential without a cap on appreciation or you are unwilling to invest in the notes based on the maximum settlement amount of $1,296.80 for each $1,000.00 face amount of your notes.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You cannot tolerate fluctuations in the price of the notes throughout their term that may be similar to or exceed the downside fluctuations in the level of the underlier or the price of the underlier stocks.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You seek guaranteed current income from this investment or prefer to receive the dividends paid on the underlier stocks.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You are unable or unwilling to hold the notes to maturity, a term of approximately 25 months, or you seek an investment for which there will be an active secondary market. </font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You do not seek an investment with exposure to companies in the developed markets of Europe, Asia, Australia and the Far East.</font></FONT></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; color: black; font-size: 8.0pt; ">&#9830;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>You are not willing to assume the credit risk of UBS for all payments under the notes.</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The investor suitability considerations identified above are not exhaustive. Whether or not the notes are a suitable investment for you will depend on your individual circumstances. You are urged to consult your investment, legal, tax, accounting and other advisors and carefully consider the suitability of an investment in the notes in light of your particular circumstances. You should also review &#8220;Additional Risk Factors Specific to Your Notes&#8221; herein and the more detailed &#8220;Risk Factors&#8221; in the accompanying product supplement for risks related to an investment in the notes.</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>1</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; text-transform: uppercase; "><font style='white-space: pre-wrap;'>KEY TERMS</font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Issuer:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> UBS AG London Branch</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Underlier:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> MSCI EAFE</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> Index (Bloomberg symbol, &#8220;MXEA&#8221; &lt;Index&gt;), as maintained by MSCI Inc. (&#8220;MSCI&#8221; or the &#8220;underlier sponsor&#8221;)</font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Specified currency:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> U.S. dollars (&#8220;$&#8221;) </font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Terms to be specified in accordance with the accompanying product supplement:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 8.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>type of notes: notes linked to a single underlier</font></FONT></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 8.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>averaging dates: not applicable</font></FONT></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 8.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>cap level: yes, as described below</font></FONT></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 8.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>buffer level: yes, as described below</font></FONT></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 8.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>interest: not applicable</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Face amount:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> Each note will have a face amount of $1,000; $871,000 in the aggregate for all the offered notes; the aggregate face amount of the offered notes may be increased if the issuer, at its sole option, decides to sell an additional aggregate face amount of the notes subsequent to the date of this pricing supplement. The issue price, underwriting discount, and net proceeds of the notes in the subsequent sale may differ substantially (higher or lower) from the original issue price you paid as provided on the cover of this pricing supplement. The return (whether positive or negative) on your investment in the notes will depend in part on the issue price you pay for such notes.</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Purchase at amount other than face amount: </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The amount we will pay you at the stated maturity date for your notes will not be adjusted based on the issue price you pay for your notes, so if you acquire notes at a premium (or discount) to face amount and hold them to the stated maturity date, it could affect your investment in a number of ways. The return on your investment in such notes will be lower (or higher) than it would have been had you purchased the notes at face amount. Also, the stated buffer level would not offer the same measure of protection to your investment as would be the case if you had purchased the notes at face amount. Additionally, the cap level would be triggered at a lower (or higher) percentage return than indicated below, relative to your initial investment. See &#8220;Additional Risk Factors Specific To Your Notes &#8212;&#160;Risks Relating to Return Characteristics &#8212;&#160;If You Purchase Your Notes at a Premium to Face Amount, the Return on Your Investment Will Be Lower Than the Return on Notes Purchased at Face Amount and the Impact of Certain Key Terms of the Notes Will Be Negatively Affected&#8221; herein. </font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Supplemental discussion of U.S. federal income tax consequences:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> You will be obligated pursuant to the terms of the notes &#8212; in the absence of a statutory or regulatory change or an administrative determination or a judicial ruling to the contrary &#8212; to characterize each note for all tax purposes as a prepaid derivative contract in respect of the underlier, as described under &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the accompanying product supplement. Pursuant to this approach, based on certain factual representations received from us, our special U.S. tax counsel, Cadwalader, Wickersham &amp; Taft LLP, is of the opinion that upon the taxable disposition of your notes, it would be reasonable for you to recognize capital gain or loss equal to the difference, if any, between the amount of cash you receive at such time and your tax basis in your notes. The U.S. Internal Revenue Service (the &#8220;IRS&#8221;) might not agree with this treatment, however, in which case, the timing and character of income or loss on your note could be materially and adversely affected.</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Additionally, we will not attempt to ascertain whether any issuers of the underlier stocks would be treated as a &#8220;passive foreign investment company&#8221; (a &#8220;PFIC&#8221;) within the meaning of Section 1297 of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). If any such entity were so treated, certain adverse U.S. federal income tax consequences might apply to U.S. holders upon the taxable disposition (including cash settlement) of the notes. You should refer to information filed with the SEC or an equivalent governmental authority by such entities and consult your tax advisor regarding the possible consequences to you if any such entity is or becomes a PFIC.</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section 871(m) of the Code on certain &#8220;dividend equivalents&#8221; paid or deemed paid to a non-U.S. holder with respect to a &#8220;specified equity-linked instrument&#8221; that references one or more dividend-paying U.S. equity securities or indices containing U.S. equity securities. The withholding tax can apply even if the instrument does not provide for payments that reference dividends. U.S. Department of the Treasury (the &#8220;Treasury&#8221;) regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on specified equity-linked instruments that have a delta of one (&#8220;delta-one specified equity-linked instruments&#8221;) issued after 2016 and to all dividend equivalents paid or deemed paid on all other specified equity-linked instruments issued after 2017. However, the IRS has issued guidance that states that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not apply to specified equity-linked instruments that are not delta-one specified equity-linked instruments and are issued before January 1, 2027.</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>2</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Based on the terms of the notes and representations provided by us, our special U.S. tax counsel is of the opinion that the notes should not be securities subject to withholding tax on dividend equivalents. Our determination is not binding on the IRS, and the IRS may disagree with this determination. Furthermore, the application of Section 871(m) of the Code will depend on our determinations on the date the terms of the notes are set. If withholding is required, we will not make payments of any additional amounts.</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Nevertheless, after the date the terms are set, it is possible that your notes could be deemed to be reissued for tax purposes upon the occurrence of certain events affecting the underlier, underlier stocks or your notes, and following such occurrence your notes could be treated as delta-one specified equity-linked instruments that are subject to withholding on dividend equivalents. It is also possible that withholding tax or other tax under Section 871(m) of the Code could apply to the notes under these rules if you enter, or have entered, into certain other transactions in respect of the underlier, underlier stocks or the notes. If you enter, or have entered, into other transactions in respect of the underlier, underlier stocks or the notes, you should consult your tax advisor regarding the application of Section 871(m) of the Code to your notes in the context of your other transactions. </font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the notes, you are urged to consult your tax advisor regarding the potential application of Section 871(m) of the Code and the 30% withholding tax to an investment in the notes.</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Pursuant to final and temporary Treasury regulations and other IRS guidance, the withholding and reporting requirements under the Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;) generally apply to certain &#8220;withholdable payments&#8221; and will generally not apply to gross proceeds on a sale or disposition and will generally apply to certain foreign passthru payments only to the extent that such payments are made after the date that is two years after final regulations defining the term &#8220;foreign passthru payment&#8221; are published. We will not pay additional amounts with respect to such withholding taxes discussed above. Foreign financial institutions and non-financial foreign entities located in jurisdictions that have an intergovernmental agreement with the U.S. governing FATCA may be subject to different rules.</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Subject to the paragraph above, you should read the discussion under &#8220;Material U.S. Federal Income Tax Consequences &#8212;&#160;Foreign Account Tax Compliance Act&#8221; in the accompanying product supplement and consult your tax advisor concerning the potential application of FATCA.</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>For more information about the tax consequences of an investment in the notes, you should review carefully the section of the accompanying product supplement entitled &#8220;Material U.S. Federal Income Tax Consequences&#8221;.</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Cash settlement amount (on the stated maturity date):</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> For each $1,000 face amount of your notes, we will pay you on the stated maturity date an amount in cash equal to:</font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 8.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>if the final underlier level is </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>greater than or equal to</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> the cap level, the maximum settlement amount;</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 8.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>if the final underlier level is </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>greater than</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> the initial underlier level but </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>less than</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> the cap level, the </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>sum</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> of (1)&#160;$1,000 </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>plus</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> (2)&#160;the </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>product</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> of (i)&#160;$1,000 </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>times</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> (ii)&#160;the upside participation rate </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>times</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> (iii)&#160;the underlier return;</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 8.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>if the final underlier level is </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>equal to</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> or </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>less than</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> the initial underlier level but </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>greater than</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> or </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>equal to</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> the buffer level, $1,000; or</font></FONT></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; margin-left: 19.80pt; text-indent: -19.80pt; "><!--[if IE]<FONT style="display: inline-block; width: 19.80pt; text-indent: -19.80pt; "><![endif]--><FONT style="display: inline-block; width: 19.80pt; text-indent: 0; text-align: left; font-size: 8.0pt; ">&#9679;</FONT><!--[if IE]</FONT><![endif]--><FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>if the final underlier level is </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>less than</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> the buffer level, the </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>sum</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> of (1)&#160;$1,000 </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>plus</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> (2)&#160;the </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>product</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> of (i)&#160;$1,000 </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>times </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>(ii)&#160;the buffer rate </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>times</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> (iii)&#160;the </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>sum</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> of the underlier return </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>plus</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> the buffer amount.</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Initial underlier level:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> 3,026.84</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Final underlier level: </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>the closing level of the underlier on the determination date, except in the limited circumstances described under &#8220;General Terms of the Notes &#8212;&#160;Market Disruption Event &#8212;&#160;Consequences of a Market Disruption Event or a Non-Trading Day&#8221; and &#8220;General Terms of the Notes &#8212;&#160;Discontinuance of, Adjustments to or Benchmark Event Affecting an Index Underlier or an Index Basket Underlier; Alteration of Method of Calculation&#8221; in the accompanying product supplement</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Underlier return:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> the </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>quotient</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> of (1)&#160;the final underlier level </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>minus </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>the initial underlier level </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>divided </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>by (2)&#160;the initial underlier level, expressed as a percentage</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Upside participation rate:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> 160.00%</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Cap level:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> 118.55% of the initial underlier level</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Maximum settlement amount:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> $1,296.80</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Buffer level:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> 2,572.814, which is 85.00% of the initial underlier level</font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Buffer amount:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> 15.00%</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Buffer rate: </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>the quotient of the initial underlier level divided by the buffer level, expressed as a percentage, which equals approximately 117.65%</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Trade date:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> May 5, 2026</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>3</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Original issue date (settlement date)</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'>:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> May 8, 2026</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Determination date:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> June 7, 2028, subject to adjustment as described under &#8220;General Terms of the Notes &#8212; Determination Date&#8221; in the accompanying product supplement.</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Stated maturity date:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> June 9, 2028, subject to adjustment as described under &#8220;General Terms of the Notes &#8212;&#160;Stated Maturity Date&#8221; in the accompanying product supplement, provided, however, that if the determination date is postponed as provided under &#8220;Determination date&#8221; above, the stated maturity date will be postponed by the same number of business day(s) from but excluding the originally scheduled determination date to and including the actual determination date. </font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Additional Market Disruption Event:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> Notwithstanding any provision to the contrary in the accompanying product supplement, if the underlier is calculated and published by the underlier sponsor, a market disruption event may occur if (a) underlier stocks constituting 20% or more, by weight, of the underlier, or (b) any option or futures contracts, if available, relating to (i) the underlier or (ii) underlier stocks constituting 20% or more, by weight, of the underlier do not trade on what were the respective primary markets for those underlier stocks or contracts, as determined by the calculation agent, including when one or more applicable markets are closed for trading under ordinary circumstances.</font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>No interest:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> The offered notes do not bear interest.</font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>No redemption:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> The offered notes will not be subject to a redemption right or price dependent redemption right. </font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>No listing:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> The offered notes will not be listed on any securities exchange or interdealer quotation system.</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Closing level:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> The closing level of the underlier as reported on Bloomberg Professional</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> service (&#8220;Bloomberg&#8221;). Currently, the closing level of the underlier as reported on Bloomberg is published to fewer decimal places than the closing level published by the underlier sponsor. As a result, the closing level of the underlier reported by Bloomberg generally may be lower or higher than the closing level published by the underlier sponsor</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Business day: </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>as described under &#8220;General Terms of the Notes &#8212; Business Day&#8221; in the accompanying product supplement</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Trading day:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> When we refer to a trading day with respect to the underlier, we mean a day on which the underlier is calculated and published by the underlier sponsor, regardless of whether one or more of the principal securities markets for the underlier stocks are closed on that day.</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Use of proceeds and hedging: </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>as described under &#8220;Use of Proceeds and Hedging&#8221; in the accompanying product supplement</font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>ERISA: </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>as described under &#8220;ERISA Considerations&#8221; in the accompanying product supplement</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Supplemental plan of distribution (conflicts of interest); secondary markets (if any)</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>: UBS has agreed to sell to UBS Securities LLC, and UBS Securities LLC has agreed to purchase from UBS, the aggregate face amount of the notes specified on the front cover of this pricing supplement. UBS Securities LLC initially offered the notes to certain unaffiliated securities dealers at the original issue price set forth on the cover page of this document. We or one of our affiliates will pay a fee to iCapital Markets LLC, a broker-dealer in which an affiliate of Goldman Sachs &amp; Co. LLC, who is acting as a dealer in connection with the distribution of the notes, holds an indirect minority equity interest, for services it is providing in connection with this offering.</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>We expect to deliver the notes against payment therefor in New York, New York on May 8, 2026, which is the third business day following the date of this pricing supplement and of the pricing of the notes. Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in one business day (T&#160;+&#160;1), unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade notes on any date prior to one business day before delivery will be required, by virtue of the fact that the notes are initially expected to settle in three business days (T&#160;+&#160;3), to specify alternative settlement arrangements to prevent a failed settlement.</font></FONT></P>
                <P style="text-align: justify; text-indent: 39.6pt; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Conflicts of interest</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>: UBS Securities LLC is an affiliate of UBS and, as such, has a &#8220;conflict of interest&#8221; in the offering within the meaning of the Financial Industry Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Rule 5121. In addition, UBS will receive the net proceeds from the initial public offering of the notes, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. Consequently, the offering is being conducted in compliance with the provisions of FINRA Rule 5121.</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>4</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="text-align: justify; text-indent: 39.6pt; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>UBS Securities LLC and its affiliates may offer to buy or sell the notes in the secondary market (if any) at prices greater than UBS&#8217; internal valuation:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> The value of the notes at any time will vary based on many factors that cannot be predicted. However, the price (not including UBS Securities LLC&#8217;s or any affiliate&#8217;s customary bid-ask spreads) at which UBS Securities LLC or any affiliate would offer to buy or sell the notes immediately after the trade date in the secondary market is expected to exceed the estimated initial value of the notes as determined by reference to our internal pricing models. The amount of the excess will decline to zero on a straight line basis over a period ending no later than 3 months after the trade date, provided that UBS Securities LLC may shorten the period based on various factors, including the magnitude of purchases and other requests from and negotiated arrangements with selling agents. Notwithstanding the foregoing, UBS Securities LLC and its affiliates are not required to make a market for the notes and may stop making a market at any time. For more information about secondary market offers and the estimated initial value of the notes, see &#8220;Additional Risk Factors Specific To Your Notes &#8212;&#160;Estimated Value Considerations&#8221; and &#8220;&#8212;&#160;Risks Relating to Liquidity and Secondary Market Price Considerations&#8221; herein.</font></FONT></P>
                <P style="text-align: justify; text-indent: 39.6pt; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Prohibition on Sales to EEA Retail Investors: </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (the &#8220;EEA&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &#8220;MiFID II&#8221;); or (ii) a customer within the meaning of Directive (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129, as amended. Consequently no key information document required by Regulation (EU) No 1286/2014 (the &#8220;EU PRIIPs Regulation&#8221;) for offering or selling the notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the notes or otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation.</font></FONT></P>
                <P style="text-align: justify; text-indent: 39.6pt; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Prohibition on Sales to UK Retail Investors: </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom (the &#8220;UK&#8221;). For these purposes, a retail investor means a person who is neither: (i) a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (&#8220;EUWA&#8221;) nor (ii) a qualified investor as defined in paragraph 15 of Schedule 1 to the Public Offers and Admissions to Trading Regulations 2024. Consequently no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the &#8220;UK PRIIPs Regulation&#8221;) for offering or selling the notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the notes or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.</font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Calculation agent:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> UBS Securities LLC</font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>CUSIP no.:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> 90310ENP6</font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>ISIN no.:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> US90310ENP69</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>FDIC:</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> The notes are not bank deposits and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency.</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>5</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; text-transform: uppercase; "><font style='white-space: pre-wrap;'>HYPOTHETICAL EXAMPLES</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The following table and chart are provided for purposes of illustration only. They should not be taken as an indication or prediction of future investment results and are intended merely to illustrate the impact that the various hypothetical final underlier levels on the determination date could have on the cash settlement amount at maturity assuming all other variables remain constant. </font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The examples below are based on a range of final underlier levels that are entirely hypothetical; no one can predict what the underlier level will be on any day throughout the term of your notes, and no one can predict what the final underlier level will be on the determination date. The underlier has been volatile in the past &#8212; meaning that the underlier level has changed considerably in relatively short periods &#8212; and its performance cannot be predicted for any future period.</font></FONT></P>
                <P style="margin-top: 8.25pt; margin-bottom: 6.6pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The information in the following examples reflects hypothetical rates of return on the offered notes assuming that they are purchased on the original issue date at the face amount and held to the stated maturity date. If you sell your notes in a secondary market prior to the stated maturity date, your return will depend upon the market value of your notes at the time of sale, which may be affected by a number of factors that are not reflected in the table below such as interest rates, the volatility of the underlier and our creditworthiness. In addition, the estimated value of your notes at the time the terms of your notes were set on the trade date (as determined by reference to our pricing models) is less than the original issue price of your notes. For more information on the estimated value of your notes, see &#8220;Additional Risk Factors Specific To Your Notes &#8212;&#160;Estimated Value Considerations &#8212; The Issue Price You Pay for the Notes Exceeds Their Estimated Initial Value&#8221; herein. The information in the table also reflects the key terms and assumptions in the box below. </font></FONT></P>
                <TABLE width="100.00%" style="margin-left: 0pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="55.00%" style="width: 55.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="55.00%" style="width: 55.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Key Terms and Assumptions</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>&nbsp;</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Face amount</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>$1,000.00</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Upside participation rate</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>160.00%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Cap level</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>118.550% of the initial underlier level </font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Maximum settlement amount</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>$1,296.80</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Buffer level</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>85.00% of the initial underlier level</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Buffer rate</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Approximately 117.65%</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Buffer amount</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>15.00%</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Neither a market disruption event nor a non-trading day occurs on the originally scheduled determination date.</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>No change in or affecting any of the underlier stocks or the method by which the underlier sponsor calculates the underlier.</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD colspan="2" style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 3.3pt; margin-bottom: 3.3pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Notes are purchased on original issue date at the face amount and held to the stated maturity date.</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The actual performance of the underlier over the term of your notes, as well as the amount payable at maturity, if any, may bear little relation to the hypothetical examples shown below or to the historical underlier levels shown elsewhere herein. For information about the historical levels of the underlier during recent periods, see &#8220;The Underlier &#8212;&#160;Historical Closing Levels of the Underlier&#8221; herein. </font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Also, the hypothetical examples shown below do not take into account the effects of applicable taxes. Because of the U.S. tax treatment applicable to your notes, tax liabilities could affect the after-tax rate of return on your notes to a comparatively greater extent than the after-tax return on the underlier stocks.</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>6</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 8.25pt; margin-bottom: 6.6pt; text-align: justify; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The levels in the left column of the table below represent hypothetical final underlier levels and are expressed as percentages of the initial underlier level. The amounts in the right column represent the hypothetical cash settlement amounts, based on the corresponding hypothetical final underlier level (expressed as a percentage of the initial underlier level), and are expressed as percentages of the face amount of a note (rounded to the nearest thousandth of a percent). Thus, a hypothetical cash settlement amount of 100.000% means that the value of the cash payment that we would pay for each $1,000.00 of the outstanding face amount of the offered notes on the stated maturity date would equal 100.000% of the face amount of a note, based on the corresponding hypothetical final underlier level (expressed as a percentage of the initial underlier level) and the assumptions noted above.</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: 0pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="55.00%" style="width: 55.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="55.00%" style="width: 55.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Hypothetical Final Underlier Level</font></FONT></P>
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>(as Percentage of Initial Underlier Level)</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Hypothetical Cash Settlement Amount</font></FONT></P>
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>(as Percentage of Face Amount)</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>150.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>129.680%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>140.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>129.680%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>130.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>129.680%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>120.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>129.680%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; background-color: #DBE5F1; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>118.550%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; background-color: #DBE5F1; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>129.680%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>115.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>124.000%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>110.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>116.000%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>105.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>108.000%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; background-color: #DBE5F1; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>100.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; background-color: #DBE5F1; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>100.000%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>90.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>100.000%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; background-color: #DBE5F1; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>85.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; background-color: #DBE5F1; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>100.000%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>80.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>94.118%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>70.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>82.353%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>60.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>70.588%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>50.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>58.824%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>25.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>29.412%</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  0.50pt solid black; border-top:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; background-color: #DBE5F1; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>0.000%</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; border-bottom:  0.50pt solid black; border-top:  0.50pt solid black; border-right:  0.50pt solid black; border-left:  0.50pt solid black; background-color: #DBE5F1; ">
                            <P style="margin-top: 0.0pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>0.000%</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>If, for example, the final underlier level were determined to be 25.000% of the initial underlier level, the cash settlement amount that we would pay on your notes at maturity would be approximately 29.412% of the face amount of your notes, as shown in the table above. As a result, if you purchased your notes on the original issue date at the face amount and held them to the stated maturity date, you would lose approximately 70.588% of your investment (if you purchased your notes at a premium to face amount you would lose a correspondingly higher percentage of your investment). In addition, if the final underlier level were determined to be 150.000% of the initial underlier level, the cash settlement amount that we would pay on your notes at maturity would be capped at the maximum settlement amount (expressed as a percentage of the face amount), or 129.680% of each $1,000.00 face amount of your notes, as shown in the table above. As a result, if you held your notes to the stated maturity date, you would not benefit from any increase in the final underlier level over 118.550% of the initial underlier level.</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>7</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The following chart also shows a graphical illustration of the hypothetical cash settlement amounts (expressed as a percentage of the face amount of your notes) that we would pay on your notes on the stated maturity date, if the final underlier level (expressed as a percentage of the initial underlier level) were any of the hypothetical levels shown on the horizontal axis. The chart shows that any hypothetical final underlier level (expressed as a percentage of the initial underlier level) of less than 85.000% (the section left of the 85.000% marker on the horizontal axis) would result in a hypothetical cash settlement amount of less than 100.000% of the face amount of your notes (the section below the 100.000% marker on the vertical axis) and, accordingly, in a loss of principal to the holder of the notes. The chart also shows that any hypothetical final underlier level (expressed as a percentage of the initial underlier level) of greater than or equal to 118.550% (the section right of the 118.550% marker on the horizontal axis) would result in a capped return on your investment.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; ">                        <IMG width="440.00pt" height="254.34pt" src="image2.jpg" style="width: 440.00pt; height: 254.34pt; ">
                        </FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The cash settlement amounts shown above are entirely hypothetical; they are based on market prices for the underlier stocks that may not be achieved on the determination date and on assumptions that may prove to be erroneous. The actual market value of your notes on the stated maturity date or at any other time, including any time you may wish to sell your notes, may bear little relation to the hypothetical cash settlement amounts shown above, and these amounts should not be viewed as an indication of the financial return on an investment in the offered notes. The hypothetical cash settlement amounts on notes held to the stated maturity date in the examples above assume you purchased your notes at their face amount and have not been adjusted to reflect the actual issue price you pay for your notes. The return on your investment (whether positive or negative) in your notes will be affected by the amount you pay for your notes. If you purchase your notes for a price other than the face amount, the return on your investment will differ from, and may be significantly lower than, the hypothetical returns suggested by the above examples. Please read &#8220;Additional Risk Factors Specific To Your Notes &#8212;&#160;Risks Relating to Characteristics of the Underlier &#8212;&#160;Market Risk&#8221; and &#8220;&#8212;&#160;Risks Relating to Return Characteristics &#8212;&#160;If You Purchase Your Notes at a Premium to Face Amount, the Return on Your Investment Will Be Lower Than the Return on Notes Purchased at Face Amount and the Impact of Certain Key Terms of the Notes Will Be Negatively Affected&#8221; herein. </font></FONT></P>
                <TABLE width="100.00%" style="margin-left: auto; width: 100.00%; table-layout: fixed; border-collapse: collapse; margin-right: auto; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; min-height: 77.77pt; ">
                        <TD style="padding-top: 6.33pt; padding-left: 6.33pt; padding-right: 6.33pt; padding-bottom: 6.33pt; border-top:  0.50pt solid black; border-bottom:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 0.0pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>We cannot predict the actual final underlier level or what the market value of your notes will be on any particular trading day, nor can we predict the relationship between the underlier level and the market value of your notes at any time prior to the stated maturity date. The actual amount that you will receive, if any, at maturity and the rate of return on the offered notes will depend on the actual final underlier level, which will be determined by the calculation agent as described above. Moreover, the assumptions on which the hypothetical returns are based may turn out to be inaccurate. Consequently, the amount of cash to be paid in respect of your notes, if any, on the stated maturity date may be very different from the information reflected in the table and chart above.</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>&nbsp;</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>8</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; text-transform: uppercase; "><font style='white-space: pre-wrap;'>ADDITIONAL RISK FACTORS SPECIFIC TO YOUR NOTES</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: 0pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="110.00%" style="width: 110.00%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 6.33pt; padding-left: 6.33pt; padding-right: 6.33pt; padding-bottom: 6.33pt; border-bottom:  0.50pt solid black; border-top:  0.50pt solid black; border-left:  0.50pt solid black; border-right:  0.50pt solid black; ">
                            <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>An investment in your notes is subject to the risks described below, as well as the risks described under &#8220;Considerations Relating to Indexed Securities&#8221; in the accompanying prospectus, dated February 6, 2025, and &#8220;Risk Factors&#8221; in the accompanying product supplement, dated February 7, 2025. You should carefully review these risks as well as the terms of the notes described herein and in the accompanying prospectus, dated February 6, 2025, as supplemented by the accompanying index supplement, dated February 6, 2025 and the accompanying product supplement, dated February 7, 2025, of UBS. Your notes are a riskier investment than ordinary debt securities. Also, your notes are not equivalent to investing directly in the underlier stocks, i.e., the stocks comprising the underlier to which your notes are linked. You should carefully consider whether the offered notes are suited to your particular circumstances.</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="margin-top: 6.6pt; text-align: left; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Risks Relating to Return Characteristics</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You May Lose Your Entire Investment In The Notes</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You can lose your entire investment in the notes. The cash payment on your notes, if any, on the stated maturity date will be based on the performance of the underlier as measured from the initial underlier level set on the trade date to the closing level on the determination date. If the final underlier level is </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>less than</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> the buffer level, you will have a loss for each $1,000 of the face amount of your notes equal to the</font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> product</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> of (a) the buffer rate</font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> times</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> (b) the</font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> sum</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> of the underlier return</font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> plus</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> the buffer amount </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>times</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> (c) $1,000. Thus, you may lose your entire investment in the notes, which would include any premium to face amount you paid when you purchased the notes.</font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> </font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Specifically, you will lose approximately 1.1765% of the face amount of each of your notes for every 1% negative underlier return below the buffer level.</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Also, the market price of your notes prior to the stated maturity date may be significantly lower than the purchase price you pay for your notes. Consequently, if you sell your notes before the stated maturity date, you may receive far less than the amount of your investment in the notes.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Upside Participation Rate Applies Only At Maturity</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You should be willing to hold your notes to maturity. If you are able to sell your notes prior to maturity in the secondary market, the price you receive will likely not reflect the full economic value of the upside participation rate of the notes and the return you realize may be less than the then-current underlier return multiplied by the upside participation rate, even if such return is positive and is less than the return implied by the maximum settlement amount. You can receive the full benefit of any positive underlier return multiplied by the upside participation rate subject to the maximum settlement amount only if you hold your notes to maturity. </font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Potential for the Value of Your Notes to Increase Will Be Limited</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Your ability to participate in any change in the value of the underlier over the term of your notes and the positive effects of the upside participation rate on any positive underlier return will be limited because of the cap level. The maximum settlement amount will limit the cash settlement amount you may receive for each of your notes at maturity, no matter how much the level of the underlier may rise beyond the cap level over the term of your notes. Accordingly, the amount payable for each of your notes may be significantly less than it would have been had you invested directly in the underlier.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Your Notes Do Not Bear Interest</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You will not receive any interest payments on your notes. As a result, even if the cash settlement amount payable for your notes on the stated maturity date exceeds the face amount of your notes, the overall return you earn on your notes may be less than you would have earned by investing in a conventional debt security of comparable maturity that bears interest at a prevailing market rate.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Amount Payable on Your Notes Is Not Linked to the Level of the Underlier at Any Time Other than the Determination Date</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The final underlier level will be based on the closing level of the underlier on the determination date, except in the limited circumstances described under &#8220;General Terms of the Notes &#8212;&#160;Market Disruption Event &#8212;&#160;Consequences of a Market Disruption Event or a Non-Trading Day&#8221; and &#8220;&#8212;&#160;Discontinuance of, Adjustments to or Benchmark Event Affecting an Index Underlier or an Index Basket Underlier; Alteration of Method of Calculation&#8221; in the accompanying product supplement. Therefore, if the closing level of the underlier dropped precipitously to a level that is less than the buffer level on the determination date, the cash settlement amount for your notes may be significantly less than it would have been had the cash settlement amount been linked to the closing level of the underlier prior to such drop in the level of the underlier. Although the actual level of the underlier on the stated maturity date or at other times during the term of your notes may be higher than the final underlier level, you will not benefit from the closing level of the underlier at any time other than on the determination date.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>You Have No Shareholder Rights or Rights to Receive Any Underlier Stock</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Investing in your notes will not make you a holder of any of the underlier stocks. Neither you nor any other holder or owner of your notes will have any voting rights, any right to receive dividends or other distributions, any rights to make a claim against the underlier stocks or any other rights with respect to the underlier stocks. Your notes will be paid in cash and you will have no right to receive delivery of any underlier stocks. </font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>9</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>If You Purchase Your Notes at a Premium to Face Amount, the Return on Your Investment Will Be Lower Than the Return on Notes Purchased at Face Amount and the Impact of Certain Key Terms of the Notes Will Be Negatively Affected</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The cash settlement amount will not be adjusted based on the original issue price you pay for the notes. If you purchase notes at a price that differs from the face amount of the notes, then the return on your investment in such notes held to the stated maturity date will differ from, and may be substantially less than, the return on notes purchased at face amount. If you purchase your notes at a premium to face amount and hold them to the stated maturity date, the return on your investment in the notes will be lower than it would have been had you purchased the notes at face amount or a discount to face amount. </font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>In addition, the impact of the buffer level on the return on your investment, and the extent to which the buffer level will diminish your exposure to any negative underlier return will depend upon the price you pay for your notes relative to face amount. For example, if you purchase your notes at a premium to face amount, the buffer level, while still providing some protection against exposure to any negative underlier return, will allow a greater percentage decrease in your investment in the notes than would have been the case for notes purchased at face amount or a discount to face amount.</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 8.0pt; "><font style='white-space: pre-wrap;'> </font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Lastly, the impact of the cap level on the return on your investment, and the extent to which the cap level will diminish your exposure to any positive underlier return (as leveraged by the upside participation rate), will also depend on the price you pay for your notes relative to face amount. For example, if you purchase your notes at a premium to face amount, the cap level will only permit a lower percentage increase in your investment in the notes than would have been the case for notes purchased at face amount or a discount to face amount.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-weight: bold; font-style: italic; font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Risks Relating to Characteristics of the Underlier</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Market Risk</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The return on the notes is directly linked to the performance of the underlier and indirectly linked to the value of the underlier stocks, and the extent to which the underlier return is positive or negative. The level of the underlier can rise or fall sharply due to factors specific to the underlier stocks, as well as general market factors, such as general market volatility and levels, interest rates and economic and political conditions. You may lose some or all of your initial investment.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Underlier Reflects Price Return, Not Total Return</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The return on your notes is based on the performance of the underlier, which reflects the changes in the market prices of the underlier stocks. It is not, however, linked to a &#8220;total return&#8221; index or strategy, which, in addition to reflecting those price returns, would also reflect dividends paid on the underlier stocks. The return on your notes will not include such a total return feature or dividend component.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Notes Are Subject to Currency Exchange Risk</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Because the prices of the underlier stocks are converted into U.S. dollars by the underlier sponsor for the purposes of calculating the level of the underlier, you will be exposed to currency exchange rate risk with respect to each of the currencies in which the underlier stocks trade. Your net exposure will depend on the extent to which those currencies strengthen or weaken against the U.S. dollar and the relative weight of the underlier stocks denominated in each of those currencies. If, taking into account the relevant weighting, the U.S. dollar strengthens against those currencies, the level of the underlier will be adversely affected and consequently the payment at maturity of the notes, if any, may be reduced.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Your Notes Are Subject to Non-U.S. Securities Market Risk</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The underlier is subject to risks associated with non-U.S. securities markets. An investment in notes linked directly or indirectly to the value of securities issued by non-U.S. companies involves particular risks. Generally, non-U.S. securities markets may be more volatile than U.S. securities markets, and market developments may affect non-U.S. markets differently from U.S. securities markets. Direct or indirect government intervention to stabilize these non-U.S. markets, as well as cross shareholdings in non-U.S. companies, may affect trading prices and volumes in those markets. There is generally less publicly available information about non-U.S. companies than about those U.S. companies that are subject to the reporting requirements of the SEC, and non-U.S. companies are subject to accounting, auditing and financial reporting standards and requirements that differ from those applicable to U.S. reporting companies. Securities prices in non-U.S. countries are subject to political, economic, financial and social factors that may be unique to the particular country. These factors, which could negatively affect the non-U.S. securities markets, include the possibility of recent or future changes in the non-U.S. government&#8217;s economic and fiscal policies, the possible imposition of, or changes in, currency exchange laws or other non-U.S. laws or restrictions applicable to non-U.S. companies or investments in non-U.S. equity securities or futures contracts and the possibility of fluctuations in the rate of exchange between currencies. Moreover, certain aspects of a particular non-U.S. economy may differ favorably or unfavorably from the U.S. economy in important respects, such as growth of gross national product, rate of inflation, capital reinvestment, resources and self-sufficiency.</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>10</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Changes Affecting the Underlier, Including Regulatory Changes, Could Have An Adverse Effect On the Value of the Notes and the Amount You Will Receive at Maturity of Your Notes</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The policies of the underlier sponsor concerning the underlier, additions, deletions or substitutions of the underlier stocks and the manner in which changes affecting the underlier stocks or the issuers of any underlier stocks (such as stock dividends, reorganizations or mergers) are reflected in the underlier, could affect the level of the underlier, and, therefore, could affect the amount payable on your notes at maturity, if any, and the market value of your notes prior to maturity. The amount payable on the notes and their market value could also be affected if the underlier sponsor changes these policies, for example by changing the manner in which it calculates the underlier, or if the underlier sponsor discontinues or suspends calculation or publication of the underlier, in which case it may become difficult to determine the market value of the notes. </font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Further, indices like the underlier have been, and continue to be, the subject of regulatory guidance and proposal for reform, including the European Union&#8217;s Regulation (EU) 2016/1011. The occurrence of a benchmark event (as defined in the accompanying product supplement under &#8220;General Terms of the Notes &#8212; Discontinuance of, Adjustments to or Benchmark Event Affecting an Index Underlier or an Index Basket Underlier; Alteration of Method of Calculation&#8221;), such as the failure of a benchmark (the underlier) or the administrator (the underlier sponsor) or user of a benchmark (such as UBS) to comply with the authorization, equivalence or other requirements of the benchmarks regulation, may result in the discontinuation of the relevant benchmark or a prohibition on its use. </font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>If events such as these occur, or if the final underlier level is not available because of a market disruption event, non-trading day or for any other reason, and no successor underlier is selected, the calculation agent &#8212; which initially will be UBS Securities LLC, an affiliate of UBS &#8212; may determine the final underlier level &#8212; and thus any amount payable at maturity &#8212;in a manner it considers appropriate as described further in the accompanying product supplement under &#8220;General Terms of the Notes &#8212;&#160;Discontinuance of, Adjustments to or Benchmark Event Affecting an Index Underlier or an Index Basket Underlier; Alteration of Method of Calculation&#8221;.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>UBS Cannot Control Actions By the Underlier Sponsor and the Underlier Sponsor Has No Obligation To Consider Your Interests</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>UBS and its affiliates are not affiliated with the underlier sponsor and have no ability to control or predict its actions, including any errors in or discontinuation of public disclosure regarding methods or policies relating to the calculation of the underlier. The underlier sponsor is not involved in the notes offering in any way and has no obligation to consider your interest as an owner of the notes in taking any actions that might affect the market value of, and any amount payable at maturity on, your notes.</font></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Estimated Value Considerations</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Issue Price You Pay for the Notes Exceeds Their Estimated Initial Value</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The issue price you pay for the notes exceeds their estimated initial value as of the trade date due to the inclusion in the issue price of hedging costs, issuance and other costs and projected profits. As of the close of the relevant markets on the trade date, we have determined the estimated initial value of the notes by reference to our internal pricing models and it is set forth in this pricing supplement. The pricing models used to determine the estimated initial value of the notes incorporate certain variables, including the level of the underlier, the volatility of the underlier, any expected dividends on the underlier stocks, prevailing interest rates, the term of the notes and our internal funding rate. Our internal funding rate is typically lower than the rate we would pay to issue conventional fixed or floating rate debt securities of a similar term. Hedging costs, issuance and other costs, projected profits and the difference in rates will reduce the economic value of the notes to you. Due to these factors, the estimated initial value of the notes as of the trade date is less than the issue price you pay for the notes.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Estimated Initial Value Is a Theoretical Price; the Actual Price that You May Be Able to Sell Your Notes in Any Secondary Market (if Any) at Any Time After the Trade Date May Differ From the Estimated Initial Value</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The value of your notes at any time will vary based on many factors, including the factors described above and in &#8220;Risks Relating to Characteristics of the Underlier &#8212;&#160;Market Risk&#8221; above and is impossible to predict. Furthermore, the pricing models that we use are proprietary and rely in part on certain assumptions about future events, which may prove to be incorrect. As a result, after the trade date, if you attempt to sell the notes in the secondary market, the actual value you would receive may differ, perhaps materially, from the estimated initial value of the notes determined by reference to our internal pricing models. The estimated initial value of the notes does not represent a minimum or maximum price at which we or any of our affiliates would be willing to purchase your notes in any secondary market at any time.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Our Actual Profits May Be Greater or Less than the Differential Between the Estimated Initial Value and the Issue Price of the Notes as of the Trade Date</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>We may determine the economic terms of the notes, as well as hedge our obligations, at least in part, prior to the trade date. In addition, there may be ongoing costs to us to maintain and/or adjust any hedges and such hedges are often imperfect. Therefore, our actual profits (or potentially, losses) in issuing the notes cannot be determined as of the trade date and any such differential between the estimated initial value and the issue price of the notes as of the trade date does not reflect our actual profits. Ultimately, our actual profits will be known only at the maturity of the notes.</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>11</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; text-align: left; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Risks Relating to Liquidity and Secondary Market Price Considerations</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>There May Be Little or No Secondary Market for the Notes</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The notes will not be listed or displayed on any securities exchange or any electronic communications network. There can be no assurance that a secondary market for the notes will develop. UBS Securities LLC and its affiliates may make a market in the notes, although they are not required to do so and may stop making a market at any time. If you are able to sell your notes prior to maturity, you may have to sell them at a substantial loss. The estimated initial value of the notes does not represent a minimum or maximum price at which we or any of our affiliates would be willing to purchase your notes in any secondary market at any time.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Price at which UBS Securities LLC and Its Affiliates May Offer to Buy the Notes in the Secondary Market (if Any) May Be Greater than UBS&#8217; Valuation of the Notes at that Time, Greater than Any Other Secondary Market Prices Provided by Unaffiliated Dealers (if Any) and, Depending on Your Broker, Greater than the Valuation Provided on Your Customer Account Statements</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>For a limited period of time following the issuance of the notes, UBS Securities LLC or its affiliates may offer to buy or sell such notes at a price that exceeds (i) our valuation of the notes at that time based on our internal pricing models, (ii) any secondary market prices provided by unaffiliated dealers (if any) and (iii) depending on your broker, the valuation provided on customer account statements. The price that UBS Securities LLC may initially offer to buy such notes following issuance will exceed the valuations indicated by our internal pricing models due to the inclusion for a limited period of time of the aggregate value of hedging costs, issuance and other costs and theoretical projected trading profit. The portion of such amounts included in our price will decline to zero on a straight line basis over a period ending no later than the date specified under &#8220;Summary Information &#8212;&#160;Key Terms &#8212;&#160;&#8220;Supplemental plan of distribution (conflicts of interest); secondary markets (if any)&#8221; herein. Thereafter, if UBS Securities LLC or an affiliate makes secondary markets in the notes, it will do so at prices that reflect our estimated value determined by reference to our internal pricing models at that time. The temporary positive differential relative to our internal pricing models arises from requests from and arrangements made by UBS Securities LLC with the selling agents of structured debt securities such as the notes. As described above, UBS Securities LLC and its affiliates are not required to make a market for the notes and may stop making a market at any time. The price at which UBS Securities LLC or an affiliate may make secondary markets at any time (if at all) will also reflect its then current bid-ask spread for similar sized trades of structured debt securities. UBS Securities LLC reflects this temporary positive differential on its customer statements. Investors should inquire as to the valuation provided on customer account statements provided by unaffiliated dealers.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Price of Notes Prior to Maturity</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The market price of the notes will be influenced by many unpredictable and interrelated factors, including the level of the underlier; the volatility of the underlier; the dividend rate paid on the underlier stocks; the time remaining to the maturity of the notes; interest rates in the markets; geopolitical conditions and economic, financial, political, force majeure and regulatory or judicial events; the creditworthiness of UBS and the then current bid-ask spread for the notes.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Impact of Fees and the Use of Internal Funding Rates Rather than Secondary Market Credit Spreads on Secondary Market Prices</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>All other things being equal, the use of the internal funding rates described above under &#8220;&#8212;&#160;Estimated Value Considerations&#8221; as well as the inclusion in the original issue price of hedging costs, issuance and other costs and any projected profits are, subject to the temporary mitigating effect of UBS Securities LLC&#8217;s and its affiliates&#8217; market making premium, expected to reduce the price at which you may be able to sell the notes in any secondary market.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>If the Level of the Underlier Changes, the Market Value of Your Notes May Not Change in the Same Manner</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Your notes may trade quite differently from the performance of the underlier. Changes in the level of the underlier may not result in a comparable change in the market value of your notes. This is because your cash settlement amount at maturity will be based on the final underlier level and subject to the maximum settlement amount. If the underlier return is negative and the final underlier level is less than the buffer level, you could lose all or a substantial portion of your investment in the notes. We discuss some of the reasons for this disparity under &#8220;Risk Factors &#8212;&#160;Risks Related to Liquidity and Secondary Market Issues &#8212;&#160;The market value of the notes may be influenced by unpredictable factors&#8221; in the accompanying product supplement.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Notes are Considered &#8220;Hold To Maturity&#8221; Products</font></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Generally, there is no liquid market for the notes.</font></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Risks Relating to Hedging Activities and Conflicts of Interest</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Potential Conflict of Interest</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>UBS and its affiliates may engage in business related to the underlier or underlier stocks, which may present a conflict between the obligations of UBS and you, as a holder of the notes. There are also potential conflicts of interest between you and the calculation agent, which will be an affiliate of UBS. The calculation agent will determine the underlier return and the cash settlement amount, if any, based on the closing level of the underlier on the determination date. The calculation agent can postpone the determination of the final underlier level if a market disruption event occurs and is continuing on the determination date. As UBS determines the economic terms of the notes, including the upside participation rate, the cap level and the buffer level, and such terms include hedging costs, issuance and other costs </font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>12</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>and projected profits, the notes represent a package of economic terms. There are other potential conflicts of interest insofar as an investor could potentially get better economic terms if that investor entered into exchange-traded and/or OTC derivatives or other instruments with third parties, assuming that such instruments were available and the investor had the ability to assemble and enter into such instruments. </font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Furthermore, given that UBS Securities LLC and its affiliates temporarily maintain a market making premium, it may have the effect of discouraging UBS Securities LLC and its affiliates from recommending the sale of your notes in the secondary market. UBS or its affiliates may earn additional profits (or potentially incur losses) as a result of payments pursuant to such hedging activities. In performing these duties, the economic interests of UBS, UBS Securities LLC, the dealers or their respective affiliates are potentially adverse to your interests as an investor in the notes. Additionally, hedging activities may adversely affect the market value of your notes and the amount we will pay on your notes. </font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Potentially Inconsistent Research, Opinions or Recommendations By UBS</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>UBS and its affiliates publish research from time to time on financial markets and other matters that may influence the value of the notes, or express opinions or provide recommendations that are inconsistent with purchasing or holding the notes. Any research, opinions or recommendations expressed by UBS or its affiliates may not be consistent with each other and may be modified from time to time without notice. Investors should make their own independent investigation of the merits of investing in the notes and the underlier to which the notes are linked.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Risks Relating to General Credit Characteristics</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Notes Are Subject to the Credit Risk of the Issuer </font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The notes are unsubordinated, unsecured debt obligations of the issuer, UBS, and are not, either directly or indirectly, an obligation of any third party. Any payment to be made on the notes, including any repayment of principal, depends on the ability of UBS to satisfy its obligations as they come due. As a result, the actual and perceived creditworthiness of UBS may affect the market value of the notes and, in the event UBS were to default on its obligations, you may not receive any amounts owed to you under the terms of the notes and you could lose your entire initial investment.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Notes Are Not Bank Deposits</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>An investment in the notes carries risks which are very different from the risk profile of a bank deposit placed with UBS or its affiliates. The notes have different yield and/or return, liquidity and risk profiles and would not benefit from any protection provided to deposits.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>If UBS Experiences Financial Difficulties, FINMA Has the Power to Open Restructuring or Liquidation Proceedings in Respect of, and/or Impose Protective Measures in Relation to, UBS, Which Proceedings or Measures May Have a Material Adverse Effect on the Terms and Market Value of the Notes and/or the Ability of UBS to Make Payments Thereunder</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The Swiss Federal Act on Banks and Savings Banks of November 8, 1934, as amended (the &#8220;Swiss Banking Act&#8221;) grants the Swiss Financial Market Supervisory Authority (&#8220;FINMA&#8221;) broad powers to take measures and actions in relation to UBS if it concludes that there is justified concern that UBS is over-indebted or has serious liquidity problems or, after expiry of a deadline, UBS fails to fulfill the applicable capital adequacy requirements (whether on a standalone or consolidated basis). If one of these pre-requisites is met, FINMA is authorized to open restructuring proceedings or liquidation (bankruptcy) proceedings in respect of, and/or impose protective measures in relation to, UBS. The Swiss Banking Act grants significant discretion to FINMA in connection with the aforementioned proceedings and measures. In particular, a broad variety of protective measures may be imposed by FINMA, including a bank moratorium or a maturity postponement, which measures may be ordered by FINMA either on a stand-alone basis or in connection with restructuring or liquidation proceedings.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>In restructuring proceedings, FINMA, as resolution authority, is competent to approve the restructuring plan. The restructuring plan may, among other things, provide for (a) the transfer of all or a portion of UBS&#8217; assets, debts, other liabilities and contracts (which may or may not include the contractual relationship between UBS and the holders of notes) to another entity, (b) a stay (for a maximum of two business days) on the termination of contracts to which UBS is a party, and/or the exercise of (w) rights to terminate, (x) netting rights, (y) rights to enforce or dispose of collateral or (z) rights to transfer claims, liabilities or collateral under contracts to which UBS is a party, (c) the partial or full conversion of UBS&#8217; debt and/or other obligations, including its obligations under the notes, into equity (a &#8220;debt-to-equity swap&#8221;), and/or (d) the partial or full write-off of obligations owed by UBS (a &#8220;write-off&#8221;), including its obligations under the notes. Prior to any debt-to-equity swap or write-off with respect to any notes, outstanding equity and debt instruments issued by UBS qualifying as additional tier 1 capital or tier 2 capital must be converted or written-down, as applicable, and cancelled. The Swiss Banking Act addresses the order in which a debt-to-equity swap or a write-off of debt instruments (other than debt instruments qualifying as additional tier 1 capital or tier 2 capital) should occur: first, all subordinated obligations not qualifying as regulatory capital; second, debt instruments for loss absorbency in the course of insolvency measures (</font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Schuldinstrumente zur Verlusttragung im Falle von Insolvenzmassnahmen</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>) under the Swiss Ordinance concerning Capital Adequacy and Risk Diversification for Banks and Securities Dealers of June 1, 2012, as amended; third, all other obligations not excluded by law from a debt-to-equity swap or write-off (other than deposits), such as the notes; and fourth, deposits to the extent in excess of the amount privileged by law. However, given the broad discretion granted to FINMA, any restructuring plan approved by FINMA in connection with restructuring proceedings with respect to UBS could provide that the claims under or in connection with the notes will be fully or partially converted into equity or written-off, while preserving other obligations of UBS that rank </font></FONT><FONT style="font-family: Arial, sans-serif; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>pari passu</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> with UBS&#8217; obligations under the notes. Consequently, the exercise by FINMA of any of its statutory resolution powers or any suggestion of any such exercise could materially adversely affect the rights of holders of the notes, the price or value of their investment </font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>13</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>in the notes and/or the ability of UBS to satisfy its obligations under the notes and could lead to holders losing some or all of their investment in the notes.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Once FINMA has opened restructuring proceedings with respect to UBS, it may consider factors such as the results of operations, financial condition (in particular, the level of indebtedness, potential future losses and/or restructuring costs), liquidity profile and regulatory capital adequacy of UBS and its subsidiaries, or any other factors of its choosing, when determining whether to exercise any of its statutory resolution powers with respect to UBS, including, if it chooses to exercise such powers to order a debt-to-equity swap and/or a write-off, whether to do so in full or in part. The criteria that FINMA may consider in exercising any statutory resolution power provide it with considerable discretion. Therefore, holders of the notes may not be able to refer to publicly available criteria in order to anticipate a potential exercise of any such power and, consequently, its potential effects on the notes and/or UBS.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>If UBS were to be subject to restructuring proceedings, the creditors whose claims are affected by the restructuring plan would not have a right to vote on, reject, or seek the suspension of the restructuring plan. In addition, if a restructuring plan with respect to UBS has been approved by FINMA, the rights of a creditor to challenge the restructuring plan or have the restructuring plan reviewed by a judicial or administrative process or otherwise (e.g., on the grounds that the plan would unduly prejudice the rights of holders of notes or otherwise be in violation of the Swiss Banking Act) are very limited. Even if any of UBS&#8217; creditors were to successfully challenge the restructuring plan in court, the court could only require the relevant creditors to be compensated ex post and there is currently no guidance as to on what basis such compensation would be calculated and how it would be funded. Any such challenge (even if successful) would not suspend, or result in the suspension of, the implementation of the restructuring plan.</font></FONT></P>
                <P style="margin-top: 6.6pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Risks Relating to U.S. Federal Income Taxation</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Uncertain Tax Treatment </font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Significant aspects of the tax treatment of the notes are uncertain. There are no statutory provisions, regulations, published rulings, judicial decisions or administrative determinations addressing the characterization for U.S. federal income tax purposes of securities with terms that are substantially the same as the notes, and we do not plan to request a ruling from the IRS. Consequently, significant aspects of the tax treatment of the notes are uncertain, and the IRS or a court might not agree with the treatment of the notes as prepaid derivative contracts that are not debt. Accordingly, it is possible that your notes could alternatively be treated for tax purposes, and that the timing and character of the income or loss on your notes could be materially and adversely affected.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>In 2007, the IRS released a notice that may affect the taxation of holders of the notes. According to Notice 2008-2, the IRS and the Treasury are actively considering whether the holder of an instrument similar to the notes should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is possible, however, that under such guidance, holders of the notes will ultimately be required to accrue income currently and this could be applied on a retroactive basis. The IRS and the Treasury are also considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary or capital, whether non-U.S. holders of such instruments should be subject to withholding tax on any deemed income accruals, and whether the special &#8220;constructive ownership rules&#8221; of Section 1260 of the Code should be applied to such instruments. Holders are urged to consult their tax advisors concerning the significance, and the potential impact, of the above considerations. Except to the extent otherwise required by law, UBS intends to treat your notes for U.S. federal income tax purposes in accordance with the treatment described above under &#8220;Supplemental discussion of U.S. federal income tax consequences&#8221; and under &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the accompanying product supplement, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Purchasers of notes should consult their tax advisors as to the U.S. federal, state, local, non-U.S. and other tax consequences to them of the purchase, ownership and disposition of the notes. For more information, see &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the accompanying product supplement.</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>General Risk Factors</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>We May Sell an Additional Aggregate Face Amount of the Notes at a Different Issue Price</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>At our sole option, we may decide to sell an additional aggregate face amount of the notes subsequent to the date of this pricing supplement. The issue price, underwriting discount and net proceeds of the notes in the subsequent sale may differ substantially (higher or lower) from the original issue price you paid as provided on the cover of this pricing supplement. The return (whether positive or negative) on your investment in the notes will depend in part on the issue price you pay for such notes.</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>14</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-weight: bold; color: black; font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>VALIDITY OF THE NOTES</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>In the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP, as special counsel to the issuer, when the notes offered by this pricing supplement have been executed and issued by the issuer and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the notes will be valid and binding obligations of the issuer, enforceable against the issuer in accordance with their terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors&#8217; rights generally, and to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Swiss law, Fried, Frank, Harris, Shriver &amp; Jacobson LLP has assumed, without independent inquiry or investigation, the validity of the matters opined on by Homburger AG, Swiss legal counsel for the issuer, in its opinion dated April 20, 2026 filed on that date with the Securities and Exchange Commission as an exhibit to a Current Report on Form 6-K and incorporated by reference into the issuer&#8217;s registration statement on Form F-3 (the &#8220;Registration Statement&#8221;). In addition, this opinion is subject to customary assumptions about the trustee&#8217;s authorization, execution and delivery of the indenture and, with respect to the notes, authentication of the notes and the genuineness of signatures and certain factual matters, all as stated in the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP dated December 6, 2024 filed with the Securities and Exchange Commission as Exhibit 5.4 to the Registration Statement.</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>15</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 9.0pt; text-transform: uppercase; "><font style='white-space: pre-wrap;'>THE UNDERLIER</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>We have derived all information contained herein regarding the MSCI EAFE</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> Index (&#8220;MSCI EAFE&#8221;), including without limitation, its make-up, method of calculation and changes in its components from publicly available information. Such information reflects the policies of, and is subject to change by MSCI Inc. (&#8220;MSCI&#8221;). UBS has not conducted any independent review or due diligence of any publicly available information with respect to MSCI EAFE. </font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>As discussed more fully in the accompanying index supplement under the heading &#8220;Underlying Indices and Underlying Index Publishers &#8212; Non-U.S. Indices &#8212; MSCI Indexes&#8221; and &#8220; &#8212; MSCI</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'> EAFE Index</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7pt; vertical-align: super; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>&#8221;, the MSCI EAFE is a free float-adjusted market capitalization index that is designed to measure large- and mid-capitalization developed market equities, excluding the U.S. and Canada. The MSCI EAFE includes components from all countries in Europe, Asia and Australia that are designated by MSCI as &#8220;developed markets&#8221;. Additional information about the MSCI Global Investable Market Indices and the MSCI EAFE (including sector and country weightings), including the sectors, sector weightings and top constituents, is available on MSCI&#8217;s website.</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Information from outside sources is not incorporated by reference in, and should not be considered part of, this document or any document incorporated herein by reference. Information about the MSCI EAFE, including the methodology used to calculate the MSCI EAFE, is available at msci.com/index-methodology. We are not incorporating by reference the website or any material it includes herein or any document incorporated herein by reference.</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>16</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-weight: bold; color: black; font-size: 9.0pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Historical Closing Levels of the Underlier</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The closing level of the underlier has fluctuated in the past and may, in the future, experience significant fluctuations. Any historical upward or downward trend in the closing level of the underlier shown below is not an indication that the underlier is more or less likely to increase or decrease at any time during the term of your notes.</font></FONT></P>
                <P style="text-align: justify; margin-top: 8.25pt; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>The following graph illustrates the performance of the underlier from January 1, 2016 through May 5, 2026, based on information reported by Bloomberg, without independent verification. Bloomberg reports the closing level of the underlier to fewer decimal places than the underlier sponsor. UBS has not conducted any independent review or due diligence of publicly available information obtained from Bloomberg. The dotted line represents the buffer level, which is equal to 85.00% of 3,026.84, which was the closing level of the underlier on May 5, 2026. </font></FONT><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-style: italic; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>Past performance of the underlier is not indicative of the future performance of the underlier.</font></FONT></P>
                <P style="margin-top: 13.2pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; ">                        <IMG width="471.90pt" height="317.63pt" src="image3.jpg" style="width: 471.90pt; height: 317.63pt; ">
                        </FONT></P>
                <P style="margin-top: 8.25pt; text-align: justify; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 9.0pt; "><font style='white-space: pre-wrap;'>We have not authorized anyone to provide any information or to make any representations other than those contained or incorporated by reference in this document, the accompanying product supplement, the accompanying index supplement, or the accompanying prospectus. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This document and any document incorporated herein by reference is an offer to sell only the notes offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this document and any document incorporated herein by reference is current only as of their respective dates.</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 29.70pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><FONT>17</FONT></FONT></P>
            </DIV>
        </DIV>
        <DIV style="page-break-after: always; border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
        <DIV style="margin: auto; width: 673.20pt; padding: 36pt 0; ">
            <DIV style="width: 594.00pt; padding: 39.60pt 39.60pt 0 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 10pt 39.60pt 10pt 39.60pt; position: relative; margin-bottom: 20pt; ">
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; text-transform: uppercase; font-size: 10.0pt; "><font style='white-space: pre-wrap;'>TABLE OF CONTENTS</font></FONT></P>
                <P style="text-align: center; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; text-transform: none; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Pricing Supplement</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="100.83%" style="width: 100.83%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="9.17%" style="width: 9.17%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>&nbsp;</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Page</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Summary Information</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>ii</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Investor Suitability</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>1</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Key Terms</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>2</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Hypothetical Examples</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>6</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Additional Risk Factors Specific to Your Notes</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>9</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Validity of the Notes</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>15</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>The Underlier</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>16</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="margin-top: 6.6pt; margin-bottom: 0.0pt; text-align: center; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Product Supplement dated February 7, 2025</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="100.83%" style="width: 100.83%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="9.17%" style="width: 9.17%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Product Supplement Summary</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>PS-1</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Hypothetical Returns on the Underlier-Linked Notes</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>PS-17</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Risk Factors</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>PS-32</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>General Terms of the Notes</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>PS-45</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Use of Proceeds and Hedging</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>PS-62</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Material U.S. Federal Income Tax Consequences</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>PS-63</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>ERISA Considerations</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>PS-70</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Supplemental Plan of Distribution (Conflicts of Interest)</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>PS-71</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="margin-top: 6.6pt; margin-bottom: 0.0pt; text-align: center; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Index Supplement dated February 6, 2025</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="100.83%" style="width: 100.83%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="9.17%" style="width: 9.17%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Index Supplement Summary</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-1</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Underlying Indices And Underlying Index Publishers</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-2</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Dow Jones Industrial Average</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 5pt; "><font style='white-space: pre-wrap;'>TM</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-2</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Nasdaq-100 Index</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 5pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-6</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Russell 2000</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 5pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'> Index</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-13</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>S&amp;P 500</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 5pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'> Equal Weight Index</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-21</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>S&amp;P 500</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 5pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'> Index</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-23</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>S&amp;P Select Sector Indices</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-31</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Non-U.S. Indices</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-34</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>EURO STOXX 50</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 5pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'> Index</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-34</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>EURO STOXX</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 5pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'> Banks Index</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-40</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>FTSE</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 5pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'> 100 Index</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-46</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>MSCI Indexes</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-52</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 38.61pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>MSCI-EAFE</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 5pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'> Index</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-52</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 38.61pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>MSCI</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 5pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'> Emerging Markets Index</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 5pt; "><font style='white-space: pre-wrap;'>SM</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-52</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 38.61pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>MSCI</font></FONT><FONT style="vertical-align: super; font-family: Arial, sans-serif; font-size: 5pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'> Europe Index</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>IS-52</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Nikkei 225 Index</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; vertical-align: bottom; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>IS-58</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>S&amp;P/ASX 200 Index</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; vertical-align: bottom; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>IS-62</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Swiss Market Index</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; vertical-align: bottom; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>IS-70</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="padding-left: 18.81pt; margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>TOPIX</font></FONT><FONT style="font-family: Arial, sans-serif; vertical-align: super; font-size: 5pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; vertical-align: bottom; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>IS-74</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="margin-top: 6.6pt; margin-bottom: 0.0pt; text-align: center; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>Prospectus dated February 6, 2025</font></FONT></P>
                <TABLE width="100.00%" style="margin-left: -5.94pt; width: 100.00%; table-layout: fixed; border-collapse: collapse; ">
                    <TR>
                        <TD width="100.83%" style="width: 100.83%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                        <TD width="9.17%" style="width: 9.17%; border: 0; margin: 0; padding: 0; height: 0; ">
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Introduction</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>1</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Cautionary Note Regarding Forward-Looking Statements</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>3</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Incorporation of Information About UBS AG</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>6</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Where You Can Find More Information</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>7</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Presentation of Financial Information</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>8</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Limitations on Enforcement of U.S. Laws Against UBS AG, Its Management and Others</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>8</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>UBS AG</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>8</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Swiss Regulatory Powers</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>10</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Use of Proceeds</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>11</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Description of Debt Securities We May Offer</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>11</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Description of Warrants We May Offer</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>48</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Legal Ownership and Book-Entry Issuance</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>65</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Considerations Relating to Indexed Securities</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>69</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Considerations Relating to Floating Rate Securities</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>72</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Considerations Relating to Securities Denominated or Payable in or Linked to a Non-U.S. Dollar Currency</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>75</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>U.S. Tax Considerations</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>77</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Tax Considerations Under the Laws of Switzerland</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>88</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Benefit Plan Investor Considerations</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>90</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Plan of Distribution</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>92</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Validity of the Securities</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>95</font></FONT></P>
                        </TD>
                    </TR>
                    <TR style="vertical-align: top; ">
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 7.5pt; "><font style='white-space: pre-wrap;'>Experts</font></FONT></P>
                        </TD>
                        <TD style="padding-top: 0.0pt; padding-left: 5.94pt; padding-right: 5.94pt; padding-bottom: 0.0pt; ">
                            <P style="margin-bottom: 0.0pt; text-align: center; margin-top: 0; "><FONT style="font-size: 7.5pt; font-family: Arial, sans-serif; "><font style='white-space: pre-wrap;'>95</font></FONT></P>
                        </TD>
                    </TR>
                </TABLE>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 18.0pt; "><font style='white-space: pre-wrap;'>$871,000</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 18.0pt; "><font style='white-space: pre-wrap;'>UBS AG</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><font style='white-space: pre-wrap;'>Capped Leveraged Buffered MSCI EAFE</font></FONT><FONT style="font-family: Arial, sans-serif; vertical-align: super; font-size: 8pt; "><font style='white-space: pre-wrap;'>&#174;</font></FONT><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; "><font style='white-space: pre-wrap;'> Index-Linked Medium-Term Notes due June 9, 2028</font></FONT></P>
                <P style="margin-top: 6.6pt; text-align: center; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-weight: bold; font-size: 18.0pt; "><font style='white-space: pre-wrap;'>UBS Securities LLC</font></FONT></P>
            </DIV>
            <DIV style="width: 594.00pt; padding: 0 39.60pt 30.08pt 39.60pt; min-height: 39.60pt; position: relative; ">
                <P style="margin-top: 0; margin-bottom: 0; "><FONT style="font-family: Arial, sans-serif; font-size: 10.0pt; ">&nbsp;</FONT></P>
            </DIV>
        </DIV>
        <DIV style="border-bottom: 1pt solid black; ">
            <P></P>
        </DIV>
    </BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>ex-filingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ffd="http://xbrl.sec.gov/ffd/2026" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:ubs="http://ubsag.com/20260507">
<head>
     <title>EX Filing Fees</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_026_FFD%2D2026 -->
<!-- Field: Set; Name: xdx; ID: xdx_03B_ubs_ubsag.com_20260507 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20260507_20260507 -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001114446 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Arial, Helvetica, Sans-Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-05-07" id="Fact000003" name="dei:EntityCentralIndexKey">0001114446</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2026/ffd-2026.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-05-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001114446</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-05-07</xbrli:startDate>
        <xbrli:endDate>2026-05-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><span style="font-family: times new roman; font-size: 12pt"><b>Exhibit
107.1</b></span></p>



<p style="font: 12pt/14pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><b>CALCULATION OF FILING FEE TABLES</b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 6pt; margin-bottom: 6pt"><span id="xdx_905_effd--FormTp_c20260507__20260507_z4Gvp6M75Az4" style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b><ix:nonNumeric contextRef="AsOf2026-05-07" id="Fact000009" name="ffd:FormTp">F-3</ix:nonNumeric></b></span></p>

<p style="font: 12pt/14pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: center"><b><span id="xdx_904_edei--EntityRegistrantName_c20260507__20260507_zBu0yR3RQoV"><ix:nonNumeric contextRef="AsOf2026-05-07" id="Fact000010" name="dei:EntityRegistrantName">UBS AG</ix:nonNumeric></span></b></p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 6pt; margin-bottom: 6pt"></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; visibility: hidden; text-indent: 0in"><span style="visibility: hidden; font-family: Times New Roman, Times, Serif; font-size: 10pt">Submission Type: <span id="xdx_903_effd--SubmissnTp_c20260507__20260507_zg7W1A9Qxzgd" style="visibility: hidden"><ix:nonNumeric contextRef="AsOf2026-05-07" id="Fact000011" name="ffd:SubmissnTp">424B2</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; visibility: hidden; text-align: left"><span id="xdx_901_effd--FeeExhibitTp_c20260507__20260507_zXLP7AVOgCD9" style="visibility: hidden"><ix:nonNumeric contextRef="AsOf2026-05-07" id="Fact000012" name="ffd:FeeExhibitTp">EX-FILING FEES</ix:nonNumeric></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; visibility: hidden; text-indent: 0in"><span style="visibility: hidden; font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC File No. <span id="xdx_901_effd--RegnFileNb_c20260507__20260507_zQsgNp23k5P1" style="visibility: hidden"><ix:nonNumeric contextRef="AsOf2026-05-07" id="Fact000013" name="ffd:RegnFileNb">333-283672</ix:nonNumeric></span></span></p>



<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; visibility: hidden; text-indent: 0in"><span style="visibility: hidden; font-family: Times New Roman, Times, Serif; font-size: 10pt">Final Prospectus: <span id="xdx_906_effd--FnlPrspctsFlg_c20260507__20260507_zYskVVgL3yE5" style="visibility: hidden"><ix:nonNumeric contextRef="AsOf2026-05-07" format="ixt:booleantrue" id="Fact000014" name="ffd:FnlPrspctsFlg">True</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; visibility: hidden"><span><span id="xdx_907_effd--OfferingTableNa_c20260507__20260507_zk3IBpDXXMOa"><span id="xdx_902_effd--OffsetTableNa_c20260507__20260507_ztQCbfSWYIyf" style="visibility: hidden"><span id="xdx_90C_effd--CombinedProspectusTableNa_c20260507__20260507_zV2knH1Intk8"><ix:nonNumeric contextRef="AsOf2026-05-07" id="Fact000015" name="ffd:OfferingTableNa"><ix:nonNumeric contextRef="AsOf2026-05-07" id="Fact000016" name="ffd:OffsetTableNa"><ix:nonNumeric contextRef="AsOf2026-05-07" id="Fact000017" name="ffd:CombinedProspectusTableNa">N/A</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></span></span>&#160;</span></p>




<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0; visibility: hidden"></p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 100%; margin-top: 3pt; margin-bottom: 3pt"/>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0"></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0"><span id="xdx_906_effd--NrrtvDsclsr_c20260507__20260507_zlf6oBlzxhn4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2026-05-07" escape="true" id="Fact000018" name="ffd:NrrtvDsclsr">The pricing supplement to which this Exhibit is attached is a final prospectus for the related offering.</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maximum aggregate offering price for such offering is $<span id="xdx_900_effd--NrrtvMaxAggtOfferingPric_c20260507__20260507_zBcjqOjekhVa"><ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" contextRef="AsOf2026-05-07" id="Fact000019" format="ixt:numdotdecimal" decimals="0" unitRef="USD">871,000</ix:nonFraction></span>.</span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->



<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwkAMhE/QO4R9lv4qSh8tKmKVUkR8XWyUxXZTsutPj+Qt3baIIRDCzDcjxERsaK1qZDgvyxyO2LS1tAglXpFRX9A5su0uBXdLvCljWWo7vD8wI8egY2Z+nEgnDNanMlilEM6DaBHEUwiTNIqh2Auv1zPSV1WhtkrWIHUFBVPLCq3kbkw4yjdparqh6oRsFOkUIj8c5Q/Eocs70FO+iO8G8jwT3mQYT2yYHq1zrd4WdU/CqsbG1ZmR/q/3BQhMSo8= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !J 2(# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]^****S-
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MLT^!/VA;#QEINBR6MKK/B:WL75+"[.%NH9$7))AD#Y"Y.!C[V0/T%_X)@?\
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MX8^-=4^'GCC1YM/UC1;Z2SU*RG7#0S1L593^(_$41 _L"_X)P?\ !0'X-?\
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MRT;Q]=*?/LF!VB&]'4KV\SJ.]?2G_!HR ?\ @G=XD!'_ #4*Z_\ 1,5?&_\
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M\E*^ ?\ V _$'_HZQK]#O^#=?_E$/\*/^O2\_P#2N6J^R!]N5^3_ /P=W?\
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MHI_A;^!\=4/(]^M?/NB:UJWAO6;3Q#H.H36=]874=S975NY62&9&#(ZGLP8
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MQ9<KJ/@^XNY@D;7JKMDM@3T9U^8>I&*/L@?T!4445('R+_P7,_9[\!_M"?\
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MAI/)X>\/>(KZ19WOKRYG\S4=19D"H88U3.Y0 4@R.H%4!^D'_!2K_@BI=_\
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*1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &0 K0# 2(  A$! Q$!_\0
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M@ HHHH **** "BN3^+,&H7'PS\3KI6L77A^_73YI(M2L5C:> JI8E/,5E#$
M@$J<9SC(%?-?B'Q1XJB^)FA7-KXR7^VX].LUTGP>]_<I=ZM%)99EN5B\\0S1
MI*TA=WMIG_=X$D6 2 ?8%%?.OP:\:6D7@WQK=>&/%MQXIT:""U&GZCJVKR7X
M.K2P8EMEN)F8[C*8!Y(.$>4HJJ?D'F \<>'O[#N%_P"%G:Y_PK@;73Q'_P )
M5=^;_;7V(L;07GF;S\^'^R[]HEQ'Y?/ET ?;-%?+^J>)-3O/B+X9L]2\3ZGH
MWQ!NHM+BM=!M]0DC2:SEMW-_<&PSY4A1_.)E9&,9AC 9<[67X8>.9/A)XP\*
M^!?$GB76/&<VH7%[I.FZL)_W,]PDH>Y9DNKR6YF$9*0C:9S$8YRWE1D!0#Z?
MHKG?%?B^3PHL+G0]2U."1XH1-9-;A1))((T0B25#DLRC.,#/)'.*W_"9:O\
M]")X@_[_ .G?_)= '5T5RG_"9:O_ -")X@_[_P"G?_)='_"9:O\ ]")X@_[_
M .G?_)= '5T5RG_"9:O_ -")X@_[_P"G?_)='_"9:O\ ]")X@_[_ .G?_)=
M'5T5RG_"9:O_ -")X@_[_P"G?_)='_"9:O\ ]")X@_[_ .G?_)= '5T5RG_"
M9:O_ -")X@_[_P"G?_)='_"9:O\ ]")X@_[_ .G?_)= '5T5RG_"9:O_ -")
MX@_[_P"G?_)='_"9:O\ ]")X@_[_ .G?_)= '5T5RG_"9:O_ -")X@_[_P"G
M?_)='_"9:O\ ]")X@_[_ .G?_)= '5T5RG_"9:O_ -")X@_[_P"G?_)='_"9
M:O\ ]")X@_[_ .G?_)= '5T5RG_"9:O_ -")X@_[_P"G?_)='_"9:O\ ]")X
M@_[_ .G?_)= '5TC<J?I7*_\)EJ__0B>(/\ O_IW_P ET?\ "9:O_P!")X@_
M[_Z=_P#)= 'YZ?L__P#!/CP)XR_9T\9>(_B)\+=6'Q(^V:P]F+Z74;.Y<*7-
ML5MUD0,"<;?D.[WJEJ'@OQ1\$OV!/@;\53H]UH7CSX4ZE)?2Z9K$;64TEG<W
M<L4]LZR ,OF*\1QC)7. <BOT8_X3+5_^A$\0?]_]._\ DNO-/BQ\'_!GQRUW
MPWK'CKX-:QXCO_#LCR::]S?6BI$69&8-&E\$D!,:?+(&''3DT ?%7QP^&>I?
M"S]A7X(_VEI2>)/%NO?$/3?$NKZ==%8O[0OKM;B9K>1FX&0R1$GC@D\5VFN?
M#3QY^U;\<OB+XPT+X=>(?A1I9^&][X.63Q5:)I\^I:C)NV *K'?$ RKYH)7$
M8Y_AKZ\^)7A32?B_I^CV/B[X7>(-6M=(U.#6+&/^T+2#R;N'=Y4F8KU2V-S?
M*V5.>0:[#_A,M7_Z$3Q!_P!_]._^2Z /SPTCPIX]^+G@3]GWX-VGP5\5?#_7
MOAYKEA?ZSXNU;3TM]-MH[4-YSVER"?/>9B'(7&7 ^\/F'8:_H'C#PS\=/VP=
M(E^'GBZ_MOB'X:WZ%K>FZ2]QITC0:5.IC:93Q([N$1 &8MP0,C/V_P#\)EJ_
M_0B>(/\ O_IW_P ET?\ "9:O_P!")X@_[_Z=_P#)= 'PEK'P:\2P_L[?L7V%
MGX&U6/5M!\7:-=ZS;0:1*)].CY:>6Y4)NB7< 79\#."37B_BC]EKQG;>.OB-
MX"USPC\:_$D_B?Q=+J%HWA;6X[#PC?VLTHD6YO9I+>=8YDP"=RL<JH^4@9_5
M7_A,M7_Z$3Q!_P!_]._^2Z/^$RU?_H1/$'_?_3O_ )+H ^2O'6A^)_AW^WK:
MZ^/!/BWQ+X9USX=IX4@US2-/:]AM[K[1N+W<@P(U"KDL1D[AA3SCPWX3_"?X
MA_"KX5?LJ_$;4?AGXF\06W@"YUZ/6_"=GIKG68/M=Q*()X[.0*S[<J_8CY3D
M#YA^D_\ PF6K_P#0B>(/^_\ IW_R71_PF6K_ /0B>(/^_P#IW_R70!\,_&_5
M_B'XR^"UKXG\&_LX7'P_BN?'4.HWL5KX?LM1\2RVH4DZHMB\&(;LLVT,2\BD
M$[PIWU\_ZS\"/B4?A7^U!:MX&^)-_J7B34?#FH:7_P )%IK7FI:C"MP\DCO)
M;JT;RJ) 7C3)B'RGE3C]9O\ A,M7_P"A$\0?]_\ 3O\ Y+H_X3+5_P#H1/$'
M_?\ T[_Y+H Z6R4I9P*P(81J"#U'%?GW\#OV$O GQ=^*?QY\0_%[X;:C<W;^
M/+^31KK49;^P2XLV<NLD022-98RQ)#X8'UQ7V_\ \)EJ_P#T(GB#_O\ Z=_\
MET?\)EJ__0B>(/\ O_IW_P ET ?(O[8_@GQ/X!U[X*Z5\-? >L6W@#2/MEK<
MZA\.O#UG?:YI6] $2T>93]E5R6+R@KGDLV< ^(_#?]G?Q;H?[#?Q>M]8TC7O
M"7CGP?XXN/&>BS>(EV3>9:QPLLHN>(Y]R1S*98SM+'(.,9_2C_A,M7_Z$3Q!
M_P!_]._^2Z\^^-'PT\,_M"Z!8:)\0?A)KOB+3+&[6^MX'U"U@V3!64-NBOD)
M^5V&TD@YY% 'R!I'P,\<_M'_ +!_Q5\:6EH#\0_BQJR>)4TWS FZSM[E/LUF
M'8@$>5$Q0M@'>N<=:[+PS;^*_P!H[]H_X&Z_IGP@\4?"71_AI970UC4?$NFK
M8"?? L265H.3-$"& ;@;78X4XW?8>DZ[=:#I5GIFG?#K6['3[.%+>WM8)-.2
M.&-%"JBJ+O     ]JM_\)EJ__0B>(/\ O_IW_P ET ?G#9?!WQZG[$7AG0F\
M$>(QKD/Q974I-,.DW'VE+7[2Y\\Q;-PBP0=Y&W'>OU)KE/\ A,M7_P"A$\0?
M]_\ 3O\ Y+H_X3+5_P#H1/$'_?\ T[_Y+H ^(/@=^PEX$^+OQ3^//B'XO?#;
M4;F[?QY?R:-=:C+?V"7%FSEUDB"21K+&6)(?# ^N*]$_:2^!L,?Q7_96T?PI
MX(DD\%^&?$,\MQ;Z9ISR6>G1*D;1O*54K&-ZYW/C+ G).:^F_P#A,M7_ .A$
M\0?]_P#3O_DNC_A,M7_Z$3Q!_P!_]._^2Z /E;X]:1XG^#G[:F@?&Q/ASXB^
M)7@Y_"DF@&W\)V(OM0TN[,[R>:EON!(<,06&!AWR<X#>$:I\ /B,/V?=3U<^
M!-7TJ;Q?\8+7Q79^#;.S:>XTBP+M\\T42_NC@#<, *%3."2!^D'_  F6K_\
M0B>(/^_^G?\ R71_PF6K_P#0B>(/^_\ IW_R70!^;O[37P<\?:_>?MC-IG@?
MQ)J*Z[JOA2323::3<2_VBL)_?-;[4/FA/XBF=O?%5?VB_@%XRT;]H;XK7]]X
M:^,_B/2?'5K:?V4?A?J"VUC> 0B)[/56:*41QJ<@,P("D_*0<C]+/^$RU?\
MZ$3Q!_W_ -._^2Z/^$RU?_H1/$'_ '_T[_Y+H I? WP2_P -O@YX*\+217-O
M)I&D6UFUO=WJWDL)2, QM.L<:R;?N[@B@A1A1TKN*Y3_ (3+5_\ H1/$'_?_
M $[_ .2Z/^$RU?\ Z$3Q!_W_ -._^2Z .KHKE/\ A,M7_P"A$\0?]_\ 3O\
MY+H_X3+5_P#H1/$'_?\ T[_Y+H ZNBN4_P"$RU?_ *$3Q!_W_P!._P#DNC_A
M,M7_ .A$\0?]_P#3O_DN@#JZ*Y3_ (3+5_\ H1/$'_?_ $[_ .2Z/^$RU?\
MZ$3Q!_W_ -._^2Z .KHKE/\ A,M7_P"A$\0?]_\ 3O\ Y+H_X3+5_P#H1/$'
M_?\ T[_Y+H ZNBN4_P"$RU?_ *$3Q!_W_P!._P#DNC_A,M7_ .A$\0?]_P#3
MO_DN@#JZ*Y3_ (3+5_\ H1/$'_?_ $[_ .2Z/^$RU?\ Z$3Q!_W_ -._^2Z
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M#/\ _)M<>G[1FG3R:I#;>$_$=U=03"'3;:);/?K7^D/ 6MLW("*KQOG[082
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M/_\ @AG_ /DVC^S?''_0Q>'_ /P0S_\ R;75T4 <I_9OCC_H8O#_ /X(9_\
MY-H_LWQQ_P!#%X?_ /!#/_\ )M=710!RG]F^./\ H8O#_P#X(9__ )-H_LWQ
MQ_T,7A__ ,$,_P#\FUU=% '*?V;XX_Z&+P__ ."&?_Y-H_LWQQ_T,7A__P $
M,_\ \FUU=% '*?V;XX_Z&+P__P""&?\ ^3:/[-\<?]#%X?\ _!#/_P#)M=71
M0!RG]F^./^AB\/\ _@AG_P#DVC^S?''_ $,7A_\ \$,__P FUU=% '*?V;XX
M_P"AB\/_ /@AG_\ DVC^S?''_0Q>'_\ P0S_ /R;75T4 <I_9OCC_H8O#_\
MX(9__DVC^S?''_0Q>'__  0S_P#R;75T4 <I_9OCC_H8O#__ ((9_P#Y-H_L
MWQQ_T,7A_P#\$,__ ,FUU=% '*?V;XX_Z&+P_P#^"&?_ .3:/[-\<?\ 0Q>'
M_P#P0S__ ";75T4 <I_9OCC_ *&+P_\ ^"&?_P"3:/[-\<?]#%X?_P#!#/\
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M_+#(6JV?B?X3ZKJ#:GXR^,7A_P 67@NYYX+&X\3P1:9;0-*7@MS91RK!<>2
MFV:='EWKO#+\JI[8/"6A  #1=/ '86L?^%'_  B>A_\ 0&T__P !4_PH Y7_
M (:$^%G_ $4OP?\ ^#ZU_P#CE'_#0GPL_P"BE^#_ /P?6O\ \<KJO^$3T/\
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MRNJ_X1/0_P#H#:?_ . J?X4?\(GH?_0&T_\ \!4_PH Y7_AH3X6?]%+\'_\
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M_"M-(_Y_/$'_ (4FH_\ Q^C_ (5II'_/YX@_\*34?_C] '5T5RG_  K32/\
MG\\0?^%)J/\ \?H_X5II'_/YX@_\*34?_C] '5T5RG_"M-(_Y_/$'_A2:C_\
M?H_X5II'_/YX@_\ "DU'_P"/T =717*?\*TTC_G\\0?^%)J/_P ?H_X5II'_
M #^>(/\ PI-1_P#C] '5T5RG_"M-(_Y_/$'_ (4FH_\ Q^C_ (5II'_/YX@_
M\*34?_C] '5T5RG_  K32/\ G\\0?^%)J/\ \?H_X5II'_/YX@_\*34?_C]
M'5T5RG_"M-(_Y_/$'_A2:C_\?H_X5II'_/YX@_\ "DU'_P"/T =717*?\*TT
MC_G\\0?^%)J/_P ?H_X5II'_ #^>(/\ PI-1_P#C] '5T5RG_"M-(_Y_/$'_
M (4FH_\ Q^C_ (5II'_/YX@_\*34?_C] '5T5RG_  K32/\ G\\0?^%)J/\
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M_"M-(_Y_/$'_ (4FH_\ Q^C_ (5II'_/YX@_\*34?_C] '5T5RG_  K32/\
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M7D-]\>;K^VM/?2_#2ZIX7G2SCGU :@([V.YNXC);Q+:F,JZD&$,YE4J91A6
M8B_\&?B[JWQ0T^WDU3PC<^%KY8))KVUNFG4VY\YD@4+/;P2GS%21SOC0J%7
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M  J;P/\ ]";X?_\ !7!_\11_PJ;P/_T)OA__ ,%<'_Q%=710!RG_  J;P/\
M]";X?_\ !7!_\11_PJ;P/_T)OA__ ,%<'_Q%=710!RG_  J;P/\ ]";X?_\
M!7!_\11_PJ;P/_T)OA__ ,%<'_Q%=710!RG_  J;P/\ ]";X?_\ !7!_\11_
MPJ;P/_T)OA__ ,%<'_Q%=710!RG_  J;P/\ ]";X?_\ !7!_\11_PJ;P/_T)
MOA__ ,%<'_Q%=710!RG_  J;P/\ ]";X?_\ !7!_\11_PJ;P/_T)OA__ ,%<
M'_Q%=710!RG_  J;P/\ ]";X?_\ !7!_\11_PJ;P/_T)OA__ ,%<'_Q%=710
M!RG_  J;P/\ ]";X?_\ !7!_\11_PJ;P/_T)OA__ ,%<'_Q%=710!RG_  J;
MP/\ ]";X?_\ !7!_\11_PJ;P/_T)OA__ ,%<'_Q%=710!RG_  J;P/\ ]";X
M?_\ !7!_\11_PJ;P/_T)OA__ ,%<'_Q%=710!RG_  J;P/\ ]";X?_\ !7!_
M\11_PJ;P/_T)OA__ ,%<'_Q%=710!RG_  J;P/\ ]";X?_\ !7!_\11_PJ;P
M/_T)OA__ ,%<'_Q%=710!RG_  J;P/\ ]";X?_\ !7!_\11_PJ;P/_T)OA__
M ,%<'_Q%=710!RG_  J;P/\ ]";X?_\ !7!_\11_PJ;P/_T)OA__ ,%<'_Q%
M=710!RG_  J;P/\ ]";X?_\ !7!_\11_PJ;P/_T)OA__ ,%<'_Q%=710!RG_
M  J;P/\ ]";X?_\ !7!_\11_PJ;P/_T)OA__ ,%<'_Q%=77%>-/BIIWA74X]
M#L;6Y\2^+9XQ+!H&E!7G"$X$LS$A+>+(/[R4J#@A=S84@$MU\,? -C:S7-SX
M3\-V]M"ADEFETVW5$4#)9B5P  ,DFO+SI6C_ !1/D?#GP/X9M=";A_&NIZ+"
M]LZ^MC!M!NCZ2L5AY#*9L%:["U^%FI^.;J'4_B9=VVK+&XFMO"MAN.D6C Y4
MR;@&O)%./GE"H" 5B0C)]/ P,#@4 >$>'OV1_@_9:[J%OJ?@/P]XMO\ [);2
MS:AXDTVUO[J1FDGRQWY$:G;PL<,48QA=P7;'T?\ PR=\$/\ HC?P_P#_  E[
M'_XU7?VTV[Q5J,7FYVV5LWE^9G;EYQG;YAQG'7RUSM^^^W$>M0!Y5_PR=\$/
M^B-_#_\ \)>Q_P#C5'_#)WP0_P"B-_#_ /\ "7L?_C5>JURWB?XCZ1X:OETU
M3+K.O%[7.AZ2%GODAGN%@6Y>+<"D"LQ9Y6PJJC'.1B@#D_\ AD[X(?\ 1&_A
M_P#^$O8__&JX3Q?\)?@/HDU_I.@? 7PAXQ\50PRF'2M+\'VOD&X2,2"WN+TP
M?9K1V5D8">16*LI56)4'T*#PSXX^(UC!_P )E=VWA#2IH4>;0/"]]<_;TF64
M,N[5$>$^64 #Q10H<Y F=?O=]HOA[2O#5O-;Z1IEGI4$]Q)=RQ65ND*R32,7
MDD8* "[,2S,>222: /!-$_8F^'=WXC.L>)/ /P_$%M=70LM#T/PC80636S/B
M!KEWA:6:=4&25:.++X\L[0Y]%\#?!_X?VW@K0(K3P5X:2V2P@$:PZ9;E OEK
MC:09 1[B1_\ >;J?1JR?"<WVCPKHTOF^=OLH6\SS/,WY0'.[S)-V?7S'S_?;
MJ0#*_P"%3>!_^A-\/_\ @K@_^(H_X5-X'_Z$WP__ ."N#_XBNKHH Y3_ (5-
MX'_Z$WP__P""N#_XBC_A4W@?_H3?#_\ X*X/_B*ZNB@#E/\ A4W@?_H3?#__
M (*X/_B*/^%3>!_^A-\/_P#@K@_^(KJZ* .4_P"%3>!_^A-\/_\ @K@_^(K*
M\,_"SP//ITS?\(CX?EQ>W:[O[/@?&+B08SNDZ8QC<,8QLCQY:^@5D^&9O/TZ
M9O-\W%[=KN\S?C%Q(,9\R3IC&-PQC&R/'EJ 97_"IO __0F^'_\ P5P?_$4?
M\*F\#_\ 0F^'_P#P5P?_ !%=710!RG_"IO __0F^'_\ P5P?_$4?\*F\#_\
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M7V]=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M (Q75T4 <I_PLO2/^?/Q!_X3>H__ !BC_A9>D?\ /GX@_P#";U'_ .,5U=%
M'*?\++TC_GS\0?\ A-ZC_P#&*/\ A9>D?\^?B#_PF]1_^,5U=% '*?\ "R](
M_P"?/Q!_X3>H_P#QBC_A9>D?\^?B#_PF]1_^,5U=% '*?\++TC_GS\0?^$WJ
M/_QBM'1/%MCX@N)(;6#4XG1=Y-]I5U:*1G'#31J">>@.:VJ* "BBB@ HHHH
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MI+>\@T*QO&BTO3;A8L2*GEI$]VA<E@;K>,JC*D9!KOH88[>)(HD6.)%"JB#
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MQQ_T+OA__P 'T_\ \A4 =717*?VEXX_Z%WP__P"#Z?\ ^0J/[2\<?]"[X?\
M_!]/_P#(5 '5T5RG]I>./^A=\/\ _@^G_P#D*C^TO''_ $+OA_\ \'T__P A
M4 =717*?VEXX_P"A=\/_ /@^G_\ D*C^TO''_0N^'_\ P?3_ /R%0!U=%<I_
M:7CC_H7?#_\ X/I__D*C^TO''_0N^'__  ?3_P#R%0!U=%<I_:7CC_H7?#__
M (/I_P#Y"H_M+QQ_T+OA_P#\'T__ ,A4 =717*?VEXX_Z%WP_P#^#Z?_ .0J
M/[2\<?\ 0N^'_P#P?3__ "%0!U=%<I_:7CC_ *%WP_\ ^#Z?_P"0J/[2\<?]
M"[X?_P#!]/\ _(5 '5T5P7B/QOXB\(:-<ZOK>G^%M*TRV7=-=W?B.:.-!T&2
M;/J3@ =22 *X1O$?Q?\ BW8+_8VA6/@'PZ[D/J%YJ,J:I?18ZV\<EH?LH/3?
M-&9,9Q&AVO0!Z#XR^*VG^&=570=-M+CQ/XNEC$D6@Z7M:9$/"RW#DA+>+(/[
MR0@'!"!VPIQ[/X5:AXTNX-4^)=Y;ZVT3B:V\,68/]CV3@Y5F5@&NY%(!$DPV
M@@,D<9Y,W@WPOKGP_P!*;3]"\'^';.*20S3ROXAN99[F4_>EFF>S+RR' R[L
MS' R:WO[2\<?]"[X?_\ !]/_ /(5 '5T5YCXP^*VK> Q:IK5AX=@O+Q96LM-
MM]:NKF^OO+4-(+:UBL6FG95.YEB1B!R1BL2[U'XM_$C3K<V6B:+X0T&:=6F-
MQJUVNI7]DR9*I_HL;V#L2!N8-*HW?+$^"H!Z/XD\?Z'X4U'2].O[MCJ6J7<=
MC9V-K"\\TDLB32("J E%*VT[>8^U (G)8!37+V.D>.O'C65_KFIOX'TCSX+U
M?#NFPH=31H9PXANKX32PO%*J 210QJ1N*"=E!+Q>#?!>K> A<OHW@[P_'>W:
M1QW>IW?B6[N[^]6/=Y7VB[FM'FGV!V"^8[;0<# XKI/[2\<?]"[X?_\ !]/_
M /(5 &CX,\&:'\//"^G>'/#>F0:/HFGQ^5;6=LN$09))]69F)9F)+,S%B223
M6U7*?VEXX_Z%WP__ .#Z?_Y"H_M+QQ_T+OA__P 'T_\ \A4 =717*?VEXX_Z
M%WP__P"#Z?\ ^0J/[2\<?]"[X?\ _!]/_P#(5 '5T5RG]I>./^A=\/\ _@^G
M_P#D*C^TO''_ $+OA_\ \'T__P A4 =717*?VEXX_P"A=\/_ /@^G_\ D*C^
MTO''_0N^'_\ P?3_ /R%0!JVTV[Q5J,7FYVV5LWE^9G;EYQG;YAQG'7RUSM^
M^^W$>M7GUMJWC<^*]1C_ +"\/G;96K>5_P )'.=N9+CG9]G.,XZ^6N=N-[[=
ML>M_:7CC_H7?#_\ X/I__D*@#JZ*Y3^TO''_ $+OA_\ \'T__P A4?VEXX_Z
M%WP__P"#Z?\ ^0J .KHKE/[2\<?]"[X?_P#!]/\ _(5']I>./^A=\/\ _@^G
M_P#D*@#JZR?"<WVCPKHTOF^=OLH6\SS/,WY0'.[S)-V?7S'S_?;J<K^TO''_
M $+OA_\ \'T__P A5D^$=6\;S^%-%D_L+P_/OLH6\T^(YY=^8UYW_9Y=V?7S
M'SUWM]X@'H-%<I_:7CC_ *%WP_\ ^#Z?_P"0J/[2\<?]"[X?_P#!]/\ _(5
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M_P#\'T__ ,A4?VEXX_Z%WP__ .#Z?_Y"H ZNBN4_M+QQ_P!"[X?_ /!]/_\
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MIK/Q'M[&Z\">&9KCP]>?9;B/Q1KLPLK.YLI5#O+:0@/<2R*K#:LT4$;YR)<
M9 .V\8>+]%\ >&-2\1>(M2@TC1--A:XN[VY;"1(._J2>  ,DD@ $D"N4GU_Q
MAXX6>UT+1YO"6F_:K_3;C6]9=8[^(Q;HXKJRM/+E2:-Y 2K3O%\JAQ&ZLN='
MPK\,[;1=0L-:UG5+WQ;XLM+)[ :]J@C23RGD,C*D,*1PQ9.U2R1AV6.,.S[0
M:[*@#EO"'PXT?P=<75]"L^HZW>R&:]UG49/-NKF5HH(I'S@+$'6U@S'$J1 Q
MKM1<"NIHHH **** "BBB@ HHHH **** "BBB@#)MIMWBK48O-SMLK9O+\S.W
M+SC.WS#C..OEKG;]]]N(]:LFVFW>*M1B\W.VRMF\OS,[<O.,[?,.,XZ^6N=O
MWWVXCUJ "BBB@ HHHH *R?"<WVCPKHTOF^=OLH6\SS/,WY0'.[S)-V?7S'S_
M 'VZG6K)\)S?:/"NC2^;YV^RA;S/,\S?E <[O,DW9]?,?/\ ?;J0#6HHHH *
M*** "BBB@ K)\,S>?ITS>;YN+V[7=YF_&+B08SYDG3&,;AC&-D>/+76K)\,S
M>?ITS>;YN+V[7=YF_&+B08SYDG3&,;AC&-D>/+4 UJ*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \W^.WQQT+X%>#7U
MC5+O2Q?RR1Q6.G:CJT&G_:6::.)F\R4X5(_-5W8 [5!.#TJW\&_B9)\4_#=U
MJDBZ IANC;C_ (1SQ!'K,! 16^:9(T"M\WW,=,'/-4OVA[Q]$^%FJZY!=^'=
M.N]*:"[6\\4RK#8K$L\;31/*T<GE^;&&C#!&(+KP37'?L;7_ /:'PWU.1/'^
ME?$>(:BO_$XT@QF)9C:6[7$8,<:+M%PTQ08RL;1J>F  >]T444 %%%86O>.=
M!\,:SHFDZIJD%EJ.M/-'86TA.Z<Q1-+*1@<*J*26. .!G+ $ W:*Y3P-\4?#
M7Q&TJ\U'0[V9[:S?9<?;K*>QDC!0.KF.=$?8R,&63&U@<J2*YK_AI7X??\(X
MVM_VIJ/V);G[*T?]A7_VD'RO.\PV_D>:(?*_>>=L\O9\V['- 'J%%<7:?&3P
MA>^*+WP_%JQ-_9V[74DC6DRVKHJ([^7<E!#*RI(C,B.S*&!( J?P/\5?#/Q%
MM+.XT&]GN%NHYI4BN;&XM9E6)U1_,CFC1X_F9<!PI8'<N1S0!+\1?^1?M/\
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M/^$-U?\ Z'OQ!_WXT[_Y$KJZ* .4_P"$-U?_ *'OQ!_WXT[_ .1*/^$-U?\
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M,DZ8QC<,8QLCQY:@&5_PANK_ /0]^(/^_&G?_(E'_"&ZO_T/?B#_ +\:=_\
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M !1110 4444 %9?B7Q1I'@W1;G5]<U&VTK3+< RW5U($1<G &3U))  '))
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M\* #6\-^*$DLM$T7X4^&=/E\)Q+:7"ZX)$M]%-B\O[U;,Q;FGG\O<R@(L1+
MM*#\K:7A/X/6>G1VU]XJU*Z\=>)S%;?:]4U<G[.\\#K*DL%D#]GM2LB(RF)
MV40L[NN\ZW_"M-(_Y_/$'_A2:C_\?H_X5II'_/YX@_\ "DU'_P"/T =717*?
M\*TTC_G\\0?^%)J/_P ?H_X5II'_ #^>(/\ PI-1_P#C] '5T5RG_"M-(_Y_
M/$'_ (4FH_\ Q^C_ (5II'_/YX@_\*34?_C] '5T5RG_  K32/\ G\\0?^%)
MJ/\ \?H_X5II'_/YX@_\*34?_C] '5T5RG_"M-(_Y_/$'_A2:C_\?H_X5II'
M_/YX@_\ "DU'_P"/T =717*?\*TTC_G\\0?^%)J/_P ?H_X5II'_ #^>(/\
MPI-1_P#C] '5T5RG_"M-(_Y_/$'_ (4FH_\ Q^C_ (5II'_/YX@_\*34?_C]
M '5T5RG_  K32/\ G\\0?^%)J/\ \?H_X5II'_/YX@_\*34?_C] '5T5RG_"
MM-(_Y_/$'_A2:C_\?H_X5II'_/YX@_\ "DU'_P"/T =717*?\*TTC_G\\0?^
M%)J/_P ?H_X5II'_ #^>(/\ PI-1_P#C] '5T5RG_"M-(_Y_/$'_ (4FH_\
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MS_H;M!_\&</_ ,50!U%%<O\ \+2\&?\ 0W:#_P"#.'_XJC_A:7@S_H;M!_\
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M>="T>#P]H>G:5;,[6UC;QVL32$%BB*%&2 .< =JO444 %%%% !1110 4444
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M)'#J7AW@NHC!+LH.E9?M.^"8DM4UC5H+2ZN]2O;"&.PM[RZ2-;:[^RM+</\
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M(M@;BCAE)P,[<UU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF",#A>#@Y .*TO\ 8F\%Z7JVMZB-;\17-SJ]Y9WEP\\MJ7+6U^+Z%3(+<22
M293=*SOL.W=P"/8;#P)8:=\0-:\8137+:GJVGV>FSQ.R^2L=L]P\94;<AB;F
M3))(P%P!@Y\ZL_VGK&_:_AA\#^*S>K<FVTNS8:>LFM$7$L#M;$W>U%5H)&/V
MAH25 (!Z5S/AO]M?PH^K>'/#OB)/L'B35+9)I84NK*/R)9&D\J#[,]U]I=R$
M7+1121J6&YU&=H!T$O[)'@^:+6(VU+6PNJ:9K^E38GARL6KW*W%TR_NN&5T
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M0Z3<M<6NTO&Q+,[$2%B=PZ;3S638_&?QKJ'QRU'PW:K#>:+9ZV--;3XO!6J
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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DB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &! CP# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\
M_"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L
M?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5
M>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4
M >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?
M\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?
M!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_H
MC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P_
M_P#"7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"
M7L?_ (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_
M (U1_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1
M_P ,G?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,
MG?!#_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#
M_HC?P_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?
MP_\ _"7L?_C5>JT4 >5?\,G?!#_HC?P__P#"7L?_ (U1_P ,G?!#_HC?P_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+O#"\1O-:\M%C_M8%65A*68NP8.@"IL)?TO_ (1SXW_]%#^'_P#X0=]_\N:
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M_P N:/\ A'/C?_T4/X?_ /A!WW_RYH ]5HKRK_A'/C?_ -%#^'__ (0=]_\
M+FC_ (1SXW_]%#^'_P#X0=]_\N: /5:*\J_X1SXW_P#10_A__P"$'??_ "YH
M_P"$<^-__10_A_\ ^$'??_+F@#U6BO*O^$<^-_\ T4/X?_\ A!WW_P N:/\
MA'/C?_T4/X?_ /A!WW_RYH ]5HKRK_A'/C?_ -%#^'__ (0=]_\ +FC_ (1S
MXW_]%#^'_P#X0=]_\N: /5:*\J_X1SXW_P#10_A__P"$'??_ "YH_P"$<^-_
M_10_A_\ ^$'??_+F@#U6BO*O^$<^-_\ T4/X?_\ A!WW_P N:/\ A'/C?_T4
M/X?_ /A!WW_RYH ]5HKRK_A'/C?_ -%#^'__ (0=]_\ +FC_ (1SXW_]%#^'
M_P#X0=]_\N: /5:*\J_X1SXW_P#10_A__P"$'??_ "YH_P"$<^-__10_A_\
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M_P#10_A__P"$'??_ "YH_P"$<^-__10_A_\ ^$'??_+F@#U6BO*O^$<^-_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?\G3_$/_ +$SPU_Z7:[7JM>5>'/^3I_B'_V)GAK_ -+M=KU6@ HHHH ****
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MP=]X(\2W/Q%C\0KXATR73H=J6VFWFD2R/:QD 3>5(MRBB1^1YC1L5!P.-P8
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MCY,1JNGKHOR_([*]*5-<U#3_ "W_ *]1/%^F7GBKXG^%[)%+Z1HI&IW\7G%
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M'=G32HPHKEIJR"HY;:*=X7DB21X6WQLR@E&VE<KZ'#,,CL2.]245B;!1110
M5SWB:TGN=:\)211/)';ZF\DK*I(C4V5TNYO0;F49]6'K70T5<)<COZ_BK$2C
MS*WI^#N%%%%06%%%% !1110!Y5^R=_R:Q\&_^Q,T;_TAAKU6O*OV3O\ DUCX
M-_\ 8F:-_P"D,->JT %%%% !7E'B?6;34_B9IVBR:)JME9V&H0ZA-J46@W4L
M=]=^7LB"SQPM&J*"-\KN,; O3<1ZO10!Y7KGBBTA^(&G^(_L>HZMH-O97^D&
M73=+GO&@O%GC$BF.-&?!\EEW@%,I@D9&>$T+2[WP?X?UK3M;\*ZI='6O#T-E
MIUE::?)>*@!N/]$D>-66';YT?,A5.3AOE./HJUM(+&!8+:&.WA3[L<2A5'.>
M *EH ^>?AUI.K67AGP+X1U/1M2;Q9HNLM>ZEJ,EC*MJ!NF:2=;LJ(Y?,60+A
M6+GS"&48;'OVHVTE[I]S;PW<UA--$T:7=N$,D+$$!T#JR%E/(W*PR.01Q5BB
M@#Y?T#X3^*'_ &DO'5HOQG\<1W$7A+P]*]\MGH7G3*UYK06-@=,*!4*,5*H&
MS*^YF 0)Z7_PIOQ=_P!%V^('_@#X>_\ E51X<_Y.G^(?_8F>&O\ TNUVO5:
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MD H<]17KG_"F_%W_ $7;X@?^ /A[_P"553:G\'++2=(U9]'+^:/"TN@6ML5
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M;55<*/H.BNQXF3PZP]M$[_U^'W'(L-%5W7OJU;^OQ^\\J_X4WXN_Z+M\0/\
MP!\/?_*JC_A3?B[_ *+M\0/_  !\/?\ RJKU6BN,ZSRK_A3?B[_HNWQ _P#
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M6\(_] CX@?\ AN/$/_R#0!ZK17E7_#2WA'_H$?$#_P -QXA_^0:/^&EO"/\
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M(?\ Y!H ]5HKRK_AI;PC_P! CX@?^&X\0_\ R#1_PTMX1_Z!'Q _\-QXA_\
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MQXA_^0: #]D[_DUCX-_]B9HW_I##7JM>5?LG?\FL?!O_ +$S1O\ TAAKU6@
MHHHH *Y'7/ $VM>+M.U\>*-9L&L,B&PMDM#;X;;Y@.^W:0[PH!^?(_AVUUU%
M ''W'A/Q#K&FK'=^,=2TFZ,]P['1HK3:8G<F.+,UNY^1,#<-I)R3VQEW?P1T
MC[/'::5JFK>'K!M/BTNZM--FC*7EM&"$21I8W<$*SKOC9'(8Y8D CT2B@#@-
M#^#.D^'[VP%KJ.I_V'IMRUY8>'F>+[#:3'=\R8C$I +N0C2,JEN%&%QW]%%
M'E7AS_DZ?XA_]B9X:_\ 2[7:]5KRKPY_R=/\0_\ L3/#7_I=KM>JT %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YGXSS:
M_&GX?[.E_P#:O-_[86TVS_TJDKTRL+6O"=MK/B/P]K3N8[O1I9GCP,ATEB:-
MUZ\<E&SS]S'>NG#U(TY-RV:DOO3M^-CFKP=2*4=TXO[FK_A<W:***YCI"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH \J_9._P"36/@W_P!B9HW_ *0PUZK7E7[)
MW_)K'P;_ .Q,T;_TAAKU6@ HHHH **** "BBB@ HHHH \J\.?\G3_$/_ +$S
MPU_Z7:[7JM>5>'/^3I_B'_V)GAK_ -+M=KU6@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#RK]D[_ )-8^#?_ &)FC?\ I##7JM>5?LG?\FL?!O\
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MM)>Z?<V\-W-8331-&EW;A#)"Q! = ZLA93R-RL,CD$<4 >9>'/\ DZ?XA_\
M8F>&O_2[7:]5KY?T#X3^*'_:2\=6B_&?QQ'<1>$O#TKWRV>A>=,K7FM!8V!T
MPH%0HQ4J@;,K[F8! GI?_"F_%W_1=OB!_P" /A[_ .55 'JM%>5?\*;\7?\
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M;X@?^ /A[_Y54 >JT5Y5_P *;\7?]%V^('_@#X>_^55'_"F_%W_1=OB!_P"
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M('_@#X>_^55'_"F_%W_1=OB!_P" /A[_ .55 'JM%>5?\*;\7?\ 1=OB!_X
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M%% !1110 4444 %%%% 'E7AS_DZ?XA_]B9X:_P#2[7:]5KRKPY_R=/\ $/\
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M'>'O_EK1_P +D\7?]$)^('_@=X>_^6M>JT4 >5?\+D\7?]$)^('_ ('>'O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIOCG0HM7TIY6M9'DBVSQ-%*CHY1E=& 92"IX(!Z>M;5 'E7_  S3X1_Z"_Q
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M $%_B!_X<?Q#_P#)U>JU0US7+#PWI<^I:G=1V5E  9)I3P,D  =R22  .22
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MLSP#Q#XY.O:SX_.E'68SX? ^(^N\6/\ 9]GO!V7V?^/O[9_K/FYX^7974_\
M#-/A'_H+_$#_ ,./XA_^3J]"\.^)=+\6Z6FHZ/?17]F[,GF1'[K X96!Y5@>
M"I (/45IT >5?\,T^$?^@O\ $#_PX_B'_P"3J/\ AFGPC_T%_B!_X<?Q#_\
M)U>JT4 >5?\ #-/A'_H+_$#_ ,./XA_^3J/^&:?"/_07^('_ (<?Q#_\G5ZK
M5'6-;T_P_9?:]3O;?3[7S$B\^YD$:;W8*BY/&2S #ZT >'^#OV9X!XA\<G7M
M9\?G2CK,9\/@?$?7>+'^S[/>#LOL_P#'W]L_UGS<\?+LKJ?^&:?"/_07^('_
M (<?Q#_\G5ZK10!Y5_PS3X1_Z"_Q _\ #C^(?_DZC_AFGPC_ -!?X@?^''\0
M_P#R=7JM% 'E7_#-/A'_ *"_Q _\./XA_P#DZC_AFGPC_P!!?X@?^''\0_\
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M'Q'UW!OO(3[0?W5]Y?\ K-_W/E].,5U/_#-/A'_H+_$#_P ./XA_^3J]5HH
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M!548 'H*=0 445F^(]>@\,Z+=:E<1RS1P*,0VZ[I)7)"HB#C+,Q51D@9(Y%
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M& 'H-%% !116/XJ\21^%M)^V-:W%_,\L=O!9VH4RSRNP5$7<0HY/)8@  DG
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MN98)%R,.I0%6&XBN1O-7TS7]?UK5_$ZZMX5GGN!#IFNB0[]$NH8UCDLW*%D
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M4JH8C)QG&1G)\3?%-AI6N#16AT_4-$FD75&UB!G^PP*CN)_(61&F60*HCV,
M=^<Y4K6#\/M(E\8:EJ>I7>F1:'=7+-I_BW0I81<6&H2"+Y987!*[^0K<GC<K
M@E5:@#I?$_A+7_'#^%M02\'A6XMQ,+^*)A-<1Q2H R12 !1)P!NP0N21D@$]
MW;6Z6EM%!'N\N) B[W+M@# RQ))/N3DTRPL8-+L;:SMD\NVMXUAB3<6VJH
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M%94*R2/*/WA8HJC=\P8&J_P^\)V'BO3]3NO[/6Q\-ZQ)-_:GAJ[B\R*/4$D
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M>8NIIQY,<D9&PB-LL'.6'W1PQKM+.SM].M(;6U@CMK:%!'%#"@1(U P%51P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
1BB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>May 07, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001114446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">UBS AG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-283672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>May 07, 2026 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text">The pricing supplement to which this Exhibit is attached is a final prospectus for the related offering.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 871,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>12</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ex-filingfees.htm">ex-filingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ffd/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ex-filingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "ex-filingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/ffd/2026/ffd-2026.xsd"
     ]
    }
   },
   "keyStandard": 12,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 1,
    "http://xbrl.sec.gov/dei/2026": 1
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2026": 10,
    "http://xbrl.sec.gov/dei/2026": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-05-07",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-05-07",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2026-05-07",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-05-07",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal8ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2026",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001839882-26-023278-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001839882-26-023278-xbrl.zip
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MLTI426))'%@B;EPW$YUW3 CV43 CG%AHZ^WK7:/M#UXKDY*T1;H\L+"K'U"
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3!@     !  $ /P    \)      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>ex-filingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2026/ffd-2026.xsd"
      xlink:type="simple"/>
    <context id="AsOf2026-05-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001114446</identifier>
        </entity>
        <period>
            <startDate>2026-05-07</startDate>
            <endDate>2026-05-07</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-05-07" id="Fact000003">0001114446</dei:EntityCentralIndexKey>
    <ffd:FormTp contextRef="AsOf2026-05-07" id="Fact000009">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="AsOf2026-05-07" id="Fact000010">UBS AG</dei:EntityRegistrantName>
    <ffd:SubmissnTp contextRef="AsOf2026-05-07" id="Fact000011">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="AsOf2026-05-07" id="Fact000012">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:RegnFileNb contextRef="AsOf2026-05-07" id="Fact000013">333-283672</ffd:RegnFileNb>
    <ffd:FnlPrspctsFlg contextRef="AsOf2026-05-07" id="Fact000014">true</ffd:FnlPrspctsFlg>
    <ffd:OfferingTableNa contextRef="AsOf2026-05-07" id="Fact000015">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="AsOf2026-05-07" id="Fact000016">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="AsOf2026-05-07" id="Fact000017">N/A</ffd:CombinedProspectusTableNa>
    <ffd:NrrtvDsclsr contextRef="AsOf2026-05-07" id="Fact000018">The pricing supplement to which this Exhibit is attached is a final prospectus for the related offering.</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="AsOf2026-05-07"
      decimals="0"
      id="Fact000019"
      unitRef="USD">871000</ffd:NrrtvMaxAggtOfferingPric>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
